| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.798 | 0.001 | 0.883 | Glutamate dehydrogenase inhibitor | 0.783 0.001 DBMET00503 0.514 0.003 DBMET00506 0.814 0.001 DBMET00508 0.883 0.001 DBMET00514 0.562 0.003 DBMET00486 | DBMET00514 | |
| 0.786 | 0.001 | 0.899 | Ornithine carbamoyltransferase inhibitor | 0.817 0.001 DBMET00503 0.804 0.001 DBMET00506 0.813 0.001 DBMET00508 0.899 0 DBMET00514 0.717 0.001 DBMET00486 | DBMET00514 | |
| 0.737 | 0.002 | 0.972 | DNA methylase inhibitor | 0.32 0.023 DBMET00503 0.547 0.005 DBMET00506 0.364 0.015 DBMET00508 0.972 0.001 DBMET00514 0.613 0.004 DBMET00486 | DBMET00514 | |
| 0.706 | 0.001 | 0.786 | Carbamoyl phosphate synthetase inhibitor | 0.437 0.003 DBMET00503 0.467 0.003 DBMET00506 0.499 0.002 DBMET00508 0.786 0 DBMET00514 0.499 0.002 DBMET00486 | DBMET00514 | |
| 0.671 | 0.003 | 0.926 | DNA methyltransferase I inhibitor | 0.316 0.021 DBMET00503 0.538 0.004 DBMET00506 0.355 0.013 DBMET00508 0.926 0.001 DBMET00514 0.54 0.004 DBMET00486 | DBMET00514 | |
| 0.605 | 0.016 | 0.634 | Immunostimulant | 0.524 0.026 DBMET00503 0.534 0.025 DBMET00506 0.551 0.022 DBMET00508 0.634 0.013 DBMET00514 0.566 0.021 DBMET00486 | DBMET00514 | |
| 0.554 | 0.004 | 0.554 | Alkylator | 0.176 0.034 DBMET00503 0.246 0.017 DBMET00506 0.208 0.024 DBMET00508 0.207 0.024 DBMET00514 0.318 0.012 DBMET00486 | ||
| 0.555 | 0.004 | 0.675 | Adenylate cyclase inhibitor | 0.208 0.024 DBMET00503 0.297 0.014 DBMET00506 0.179 0.03 DBMET00508 0.675 0.002 DBMET00514 0.156 0.041 DBMET00486 | DBMET00514 | |
| 0.551 | 0.001 | 0.777 | Argininosuccinate synthase inhibitor | 0.276 0.004 DBMET00503 0.286 0.004 DBMET00506 0.31 0.004 DBMET00508 0.777 0.001 DBMET00514 0.31 0.004 DBMET00486 | DBMET00514 | |
| 0.547 | 0.01 | 0.699 | DNA synthesis inhibitor | 0.44 0.018 DBMET00503 0.389 0.023 DBMET00506 0.397 0.022 DBMET00508 0.699 0.005 DBMET00514 0.381 0.024 DBMET00486 | DBMET00514 | |
| 0.532 | 0.001 | 0.606 | Adenylate kinase inhibitor | 0.436 0.002 DBMET00503 0.34 0.005 DBMET00506 0.443 0.002 DBMET00508 0.606 0 DBMET00514 0.359 0.004 DBMET00486 | DBMET00514 | |
| 0.536 | 0.009 | 0.579 | RNA-directed DNA polymerase inhibitor | 0.207 0.09 DBMET00503 0.21 0.085 DBMET00506 0.181 0.131 DBMET00508 0.579 0.006 DBMET00514 0.202 0.097 DBMET00486 | DBMET00514 | |
| 0.526 | 0.003 | 0.628 | NADH dehydrogenase inhibitor | 0.138 0.021 DBMET00503 0.101 0.042 DBMET00506 0.111 0.034 DBMET00508 0.628 0.002 DBMET00514 0.111 0.034 DBMET00486 | DBMET00514 | |
| 0.519 | 0.002 | 0.7 | Phosphofructokinase-1 inhibitor | 0.36 0.004 DBMET00503 0.246 0.008 DBMET00506 0.402 0.003 DBMET00508 0.7 0.001 DBMET00514 0.267 0.007 DBMET00486 | DBMET00514 | |
| 0.526 | 0.02 | 0.649 | Immunomodulator | 0.532 0.019 DBMET00503 0.521 0.02 DBMET00506 0.494 0.024 DBMET00508 0.649 0.008 DBMET00514 0.588 0.013 DBMET00486 | DBMET00514 | |
| 0.505 | 0.004 | 0.578 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.219 0.059 DBMET00503 0.182 0.09 DBMET00508 0.578 0.003 DBMET00514 | DBMET00514 | |
| 0.506 | 0.007 | 0.506 | Hepatoprotectant | 0.444 0.01 DBMET00503 0.362 0.017 DBMET00506 0.346 0.02 DBMET00508 0.218 0.055 DBMET00514 0.5 0.007 DBMET00486 | ||
| 0.55 | 0.068 | 0.55 | Antiinflammatory | 0.336 0.183 DBMET00486 | ||
| 0.409 | 0.002 | 0.763 | Fumarate hydratase inhibitor | 0.126 0.004 DBMET00503 0.099 0.005 DBMET00506 0.117 0.005 DBMET00508 0.763 0.001 DBMET00514 0.117 0.005 DBMET00486 | DBMET00514 | |
| 0.397 | 0.004 | 0.47 | Aminoacyl-tRNA synthetase inhibitor | 0.369 0.004 DBMET00503 0.381 0.004 DBMET00506 0.401 0.004 DBMET00508 0.47 0.003 DBMET00514 0.376 0.004 DBMET00486 | DBMET00514 | |
| 0.447 | 0.058 | 0.506 | Antibacterial | 0.35 0.102 DBMET00503 0.395 0.079 DBMET00506 0.374 0.089 DBMET00508 0.506 0.039 DBMET00514 0.407 0.074 DBMET00486 | DBMET00514 | |
| 0.388 | 0.001 | 0.897 | Adenosine deaminase inhibitor | 0.106 0.005 DBMET00503 0.076 0.01 DBMET00506 0.09 0.007 DBMET00508 0.897 0.001 DBMET00514 0.084 0.008 DBMET00486 | DBMET00514 | |
| 0.376 | 0.003 | 0.67 | Histamine N-methyltransferase inhibitor | 0.084 0.062 DBMET00503 0.208 0.005 DBMET00506 0.131 0.023 DBMET00508 0.67 0.001 DBMET00514 0.166 0.01 DBMET00486 | DBMET00514 | |
| 0.402 | 0.034 | 0.521 | Vasodilator, coronary | 0.281 0.104 DBMET00503 0.258 0.127 DBMET00508 0.521 0.013 DBMET00514 | DBMET00514 | |
| 0.367 | 0.007 | 0.567 | Aldehyde dehydrogenase inhibitor | 0.447 0.005 DBMET00503 0.324 0.01 DBMET00506 0.358 0.007 DBMET00508 0.567 0.004 DBMET00514 0.308 0.011 DBMET00486 | DBMET00514 | |
| 0.355 | 0.014 | 0.764 | Phospholipase C inhibitor | 0.764 0.002 DBMET00503 0.681 0.003 DBMET00506 0.727 0.003 DBMET00508 0.602 0.004 DBMET00514 0.666 0.003 DBMET00486 | DBMET00503 | |
| 0.33 | 0.005 | 0.591 | Adenosine A3 receptor antagonist | 0.591 0.002 DBMET00514 | DBMET00514 | |
| 0.331 | 0.009 | 0.362 | DNA polymerase I inhibitor | 0.362 0.008 DBMET00514 | DBMET00514 | |
| 0.312 | 0.003 | 0.426 | Biliverdin reductase inhibitor | 0.129 0.012 DBMET00503 0.088 0.023 DBMET00506 0.102 0.018 DBMET00508 0.426 0.002 DBMET00514 0.102 0.018 DBMET00486 | DBMET00514 | |
| 0.309 | 0.005 | 0.451 | Antimetabolite | 0.093 0.017 DBMET00503 0.137 0.013 DBMET00506 0.105 0.015 DBMET00508 0.451 0.003 DBMET00514 0.178 0.01 DBMET00486 | DBMET00514 | |
| 0.305 | 0.008 | 0.305 | Interleukin 4 antagonist | |||
| 0.313 | 0.02 | 0.321 | Peptidyltransferase inhibitor | 0.274 0.036 DBMET00503 0.302 0.024 DBMET00506 0.267 0.04 DBMET00508 0.321 0.018 DBMET00514 0.275 0.036 DBMET00486 | DBMET00514 | |
| 0.293 | 0.007 | 0.588 | Adenosine A1 receptor antagonist | 0.588 0.003 DBMET00514 | DBMET00514 | |
| 0.331 | 0.047 | 0.331 | DNA damaging | 0.252 0.079 DBMET00514 | ||
| 0.277 | 0.002 | 0.334 | Acyl-CoA dehydrogenase inhibitor | 0.152 0.009 DBMET00503 0.171 0.007 DBMET00506 0.134 0.011 DBMET00508 0.334 0.001 DBMET00514 0.215 0.004 DBMET00486 | DBMET00514 | |
| 0.271 | 0.003 | 0.431 | Adenosine A1 receptor agonist | 0.431 0.002 DBMET00514 | DBMET00514 | |
| 0.271 | 0.005 | 0.347 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.119 0.011 DBMET00503 0.086 0.018 DBMET00508 0.347 0.003 DBMET00514 | DBMET00514 | |
| 0.215 | 0.005 | 0.294 | Heat shock protein 70 antagonist | 0.133 0.104 DBMET00503 0.147 0.052 DBMET00506 0.294 0.003 DBMET00514 0.133 0.107 DBMET00486 | DBMET00514 | |
| 0.21 | 0.002 | 0.227 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.071 0.056 DBMET00503 0.227 0.002 DBMET00514 | DBMET00514 | |
| 0.202 | 0.003 | 0.234 | Purinergic P2X1 antagonist | 0.061 0.041 DBMET00503 0.234 0.003 DBMET00514 | DBMET00514 | |
| 0.297 | 0.098 | 0.516 | Vasodilator, peripheral | 0.516 0.025 DBMET00514 | DBMET00514 | |
| 0.2 | 0.002 | 0.226 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.226 0.002 DBMET00514 | DBMET00514 | |
| 0.198 | 0.01 | 0.424 | Adenosine A2a receptor antagonist | 0.424 0.004 DBMET00514 | DBMET00514 | |
| 0.182 | 0.012 | 0.394 | Adenosine A2 receptor antagonist | 0.394 0.004 DBMET00514 | DBMET00514 | |
| 0.233 | 0.073 | 0.372 | Cyclic AMP phosphodiesterase inhibitor | 0.372 0.021 DBMET00514 | DBMET00514 | |
| 0.18 | 0.025 | 0.235 | Adenylate cyclase stimulant | 0.183 0.024 DBMET00503 0.235 0.005 DBMET00506 0.192 0.018 DBMET00508 0.229 0.005 DBMET00514 0.2 0.014 DBMET00486 | DBMET00506 | |
| 0.173 | 0.027 | 0.686 | Expectorant | 0.686 0.002 DBMET00503 0.321 0.007 DBMET00506 0.469 0.004 DBMET00508 0.501 0.004 DBMET00514 0.53 0.003 DBMET00486 | DBMET00503 | |
| 0.167 | 0.024 | 0.231 | UDP-glucose 4-epimerase inhibitor | 0.114 0.048 DBMET00503 0.087 0.079 DBMET00508 0.231 0.015 DBMET00514 0.087 0.079 DBMET00486 | DBMET00514 | |
| 0.147 | 0.004 | 0.259 | Phosphoglycerate kinase inhibitor | 0.259 0.003 DBMET00514 | DBMET00514 | |
| 0.225 | 0.086 | 0.348 | Vasodilator | 0.269 0.06 DBMET00506 0.348 0.034 DBMET00514 0.296 0.049 DBMET00486 | DBMET00514 | |
| 0.141 | 0.003 | 0.23 | Adenosine A3 receptor agonist | 0.23 0.002 DBMET00514 | DBMET00514 | |
| 0.14 | 0.002 | 0.233 | Adenosine A2 receptor agonist | 0.233 0.001 DBMET00514 | DBMET00514 | |
| 0.133 | 0.001 | 0.154 | Purinergic P2Y1 agonist | 0.021 0.006 DBMET00503 0.022 0.006 DBMET00506 0.019 0.007 DBMET00508 0.154 0.001 DBMET00514 0.018 0.008 DBMET00486 | DBMET00514 | |
| 0.126 | 0.003 | 0.32 | Adenosine kinase inhibitor | 0.32 0.001 DBMET00514 | DBMET00514 | |
| 0.137 | 0.015 | 0.14 | Purinergic P2X2 antagonist | 0.14 0.014 DBMET00514 | DBMET00514 | |
| 0.135 | 0.016 | 0.135 | Interleukin 5 antagonist | |||
| 0.255 | 0.144 | 0.396 | Immunosuppressant | 0.326 0.1 DBMET00506 0.396 0.065 DBMET00514 0.248 0.149 DBMET00486 | DBMET00514 | |
| 0.118 | 0.007 | 0.372 | Purinergic P2Y antagonist | 0.372 0.003 DBMET00514 | DBMET00514 | |
| 0.134 | 0.045 | 0.692 | Aminopeptidase B inhibitor | 0.692 0.002 DBMET00503 0.689 0.002 DBMET00506 0.674 0.002 DBMET00508 0.215 0.018 DBMET00514 0.492 0.003 DBMET00486 | DBMET00503 | |
| 0.089 | 0.001 | 0.095 | Purinergic P2Y15 antagonist | 0.095 0.001 DBMET00514 | DBMET00514 | |
| 0.133 | 0.05 | 0.186 | DNA repair enzyme inhibitor | 0.186 0.011 DBMET00514 | DBMET00514 | |
| 0.116 | 0.038 | 0.598 | Alcohol dehydrogenase inhibitor | 0.598 0.002 DBMET00503 0.162 0.017 DBMET00506 0.564 0.003 DBMET00508 0.269 0.006 DBMET00514 0.229 0.009 DBMET00486 | DBMET00503 | |
| 0.085 | 0.007 | 0.189 | AICAR transformylase inhibitor | 0.051 0.021 DBMET00503 0.056 0.017 DBMET00506 0.048 0.024 DBMET00508 0.189 0.002 DBMET00514 0.075 0.008 DBMET00486 | DBMET00514 | |
| 0.079 | 0.004 | 0.08 | Purinergic P2X agonist | 0.08 0.004 DBMET00514 | DBMET00514 | |
| 0.079 | 0.004 | 0.104 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.037 0.014 DBMET00503 0.03 0.018 DBMET00508 0.104 0.002 DBMET00514 0.035 0.015 DBMET00486 | DBMET00514 | |
| 0.082 | 0.008 | 0.123 | Thymidine kinase inhibitor | 0.038 0.033 DBMET00503 0.123 0.005 DBMET00514 | DBMET00514 | |
| 0.092 | 0.023 | 0.183 | Ribonucleotide reductase inhibitor | 0.159 0.011 DBMET00503 0.066 0.033 DBMET00506 0.133 0.015 DBMET00508 0.183 0.009 DBMET00514 0.073 0.03 DBMET00486 | DBMET00514 | |
| 0.059 | 0.002 | 0.099 | Isoleucine-tRNA ligase inhibitor | 0.026 0.009 DBMET00503 0.041 0.003 DBMET00506 0.028 0.006 DBMET00508 0.099 0.001 DBMET00514 0.033 0.004 DBMET00486 | DBMET00514 | |
| 0.055 | 0.003 | 0.088 | Adenosine A2b receptor agonist | 0.088 0.003 DBMET00514 | DBMET00514 | |
| 0.053 | 0.002 | 0.146 | Adenosine A2a receptor agonist | 0.146 0.001 DBMET00514 | DBMET00514 | |
| 0.052 | 0.004 | 0.066 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.066 0.004 DBMET00514 | DBMET00514 | |
| 0.071 | 0.024 | 0.074 | Protein 50S ribosomal subunit inhibitor | 0.074 0.022 DBMET00514 | DBMET00514 | |
| 0.074 | 0.027 | 0.163 | Ribonucleoside-diphosphate reductase inhibitor | 0.163 0.01 DBMET00503 0.066 0.031 DBMET00506 0.137 0.013 DBMET00508 0.161 0.01 DBMET00514 0.072 0.028 DBMET00486 | DBMET00503 | |
| 0.162 | 0.115 | 0.581 | Angiogenesis stimulant | 0.488 0.012 DBMET00503 0.441 0.016 DBMET00506 0.581 0.008 DBMET00508 0.27 0.061 DBMET00514 0.467 0.014 DBMET00486 | DBMET00508 | |
| 0.055 | 0.012 | 0.292 | Arginase inhibitor | 0.247 0.001 DBMET00503 0.198 0.002 DBMET00506 0.292 0.001 DBMET00508 0.092 0.004 DBMET00514 0.251 0.001 DBMET00486 | DBMET00508 | |
| 0.167 | 0.128 | 0.434 | Platelet antagonist | 0.32 0.047 DBMET00503 0.408 0.025 DBMET00506 0.311 0.049 DBMET00508 0.259 0.069 DBMET00514 0.434 0.021 DBMET00486 | DBMET00486 | |
| 0.045 | 0.01 | 0.071 | Purinergic P2T antagonist | 0.071 0.007 DBMET00514 | DBMET00514 | |
| 0.035 | 0.002 | 0.049 | Methylmalonyl-CoA mutase inhibitor | 0.02 0.009 DBMET00503 0.021 0.007 DBMET00506 0.019 0.011 DBMET00508 0.049 0.001 DBMET00514 0.024 0.004 DBMET00486 | DBMET00514 | |
| 0.159 | 0.133 | 0.233 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.233 0.069 DBMET00514 | DBMET00514 | |
| 0.035 | 0.01 | 0.076 | Purinergic P2Y12 antagonist | 0.076 0.005 DBMET00514 | DBMET00514 | |
| 0.2 | 0.178 | 0.348 | Apoptosis antagonist | 0.348 0.056 DBMET00503 0.321 0.072 DBMET00506 0.294 0.09 DBMET00508 0.319 0.073 DBMET00514 0.3 0.085 DBMET00486 | DBMET00503 | |
| 0.084 | 0.062 | 0.137 | Transcription factor NF kappa B stimulant | 0.103 0.036 DBMET00514 0.137 0.019 DBMET00486 | DBMET00486 | |
| 0.026 | 0.005 | 0.028 | Purinergic receptor agonist | 0.028 0.005 DBMET00514 | DBMET00514 | |
| 0.026 | 0.005 | 0.028 | Purinergic P2 agonist | 0.028 0.005 DBMET00514 | DBMET00514 | |
| 0.094 | 0.077 | 0.176 | Folate antagonist | 0.159 0.019 DBMET00503 0.176 0.015 DBMET00506 0.149 0.022 DBMET00508 0.135 0.029 DBMET00514 0.162 0.018 DBMET00486 | DBMET00506 | |
| 0.097 | 0.082 | 0.664 | Mucolytic | 0.664 0.002 DBMET00503 0.295 0.004 DBMET00506 0.427 0.003 DBMET00508 0.254 0.006 DBMET00514 0.495 0.002 DBMET00486 | DBMET00503 | |
| 0.02 | 0.005 | 0.022 | Purinergic P2Y agonist | 0.022 0.005 DBMET00514 | DBMET00514 | |
| 0.015 | 0.005 | 0.025 | Purine nucleoside phosphorylase inhibitor | 0.011 0.01 DBMET00506 0.025 0.003 DBMET00514 | DBMET00514 | |
| 0.053 | 0.045 | 0.112 | Adenine nucleotide translocase inhibitor | 0.06 0.029 DBMET00503 0.076 0.011 DBMET00506 0.07 0.015 DBMET00508 0.061 0.027 DBMET00514 0.112 0.004 DBMET00486 | DBMET00486 | |
| 0.035 | 0.028 | 0.035 | Antibiotic Aminoglycoside-like | 0.035 0.026 DBMET00514 | ||
| 0.011 | 0.007 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.007 DBMET00514 | ||
| 0.16 | 0.158 | 0.333 | Interleukin agonist | 0.291 0.053 DBMET00503 0.302 0.047 DBMET00506 0.32 0.039 DBMET00508 0.333 0.034 DBMET00514 0.33 0.035 DBMET00486 | DBMET00514 | |
| 0.014 | 0.013 | 0.015 | Purinergic P2Y1 antagonist | 0.015 0.012 DBMET00514 | DBMET00514 | |
| 0.03 | 0.031 | 0.035 | Purinergic P2Y2 antagonist | 0.035 0.021 DBMET00514 | DBMET00514 | |
| 0.015 | 0.017 | 0.016 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.016 0.013 DBMET00514 | DBMET00514 | |
| 0.182 | 0.188 | 0.421 | Transcription factor NF kappa B inhibitor | 0.421 0.059 DBMET00503 0.393 0.065 DBMET00506 0.358 0.074 DBMET00508 0.305 0.091 DBMET00514 0.421 0.059 DBMET00486 | DBMET00486 | |
| 0.022 | 0.035 | 0.028 | Thymidine phosphorylase inhibitor | 0.028 0.015 DBMET00514 | DBMET00514 | |
| 0.013 | 0.026 | 0.064 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.064 0.004 DBMET00514 | DBMET00514 | |
| 0.037 | 0.051 | 0.468 | Farnesyltransferase inhibitor | 0.459 0.003 DBMET00503 0.468 0.003 DBMET00506 0.392 0.003 DBMET00508 0.187 0.004 DBMET00486 | DBMET00506 | |
| 0.111 | 0.126 | 0.321 | Insulin secretagoues | 0.182 0.047 DBMET00503 0.321 0.01 DBMET00506 0.159 0.065 DBMET00508 0.187 0.043 DBMET00514 0.152 0.072 DBMET00486 | DBMET00506 | |
| 0.062 | 0.078 | 0.07 | Phosphodiesterase VIII inhibitor | 0.07 0.054 DBMET00514 | DBMET00514 | |
| 0.065 | 0.088 | 0.078 | ErbB-3 antagonist | 0.078 0.064 DBMET00514 | DBMET00514 | |
| 0.111 | 0.136 | 0.589 | Growth hormone agonist | 0.335 0.026 DBMET00503 0.589 0.004 DBMET00506 0.407 0.015 DBMET00508 0.169 0.074 DBMET00514 0.47 0.008 DBMET00486 | DBMET00506 | |
| 0.073 | 0.1 | 0.103 | DNA directed RNA polymerase inhibitor | 0.103 0.053 DBMET00514 | DBMET00514 | |
| 0.026 | 0.053 | 0.259 | Toll-Like receptor 2 agonist | 0.198 0.007 DBMET00503 0.259 0.004 DBMET00506 0.237 0.005 DBMET00508 0.062 0.02 DBMET00514 0.246 0.004 DBMET00486 | DBMET00506 | |
| 0.189 | 0.217 | 0.235 | Toll-Like receptor agonist | 0.235 0.163 DBMET00486 | DBMET00486 | |
| 0.003 | 0.039 | 0.274 | Neurokinin 3 agonist | 0.274 0.002 DBMET00506 0.01 0.009 DBMET00508 0.019 0.004 DBMET00486 | DBMET00506 | |
| 0.022 | 0.064 | 0.077 | Inosine monophosphate dehydrogenase inhibitor | 0.077 0.007 DBMET00514 | DBMET00514 | |
| 0.028 | 0.071 | 0.059 | Geranyltranstransferase inhibitor | 0.053 0.02 DBMET00506 0.059 0.015 DBMET00486 | DBMET00486 | |
| 0.003 | 0.049 | 0.008 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.007 0.005 DBMET00506 0.008 0.005 DBMET00486 | DBMET00486 | |
| 0.069 | 0.116 | 0.463 | Hematopoietic | 0.173 0.012 DBMET00503 0.255 0.006 DBMET00506 0.185 0.011 DBMET00508 0.096 0.04 DBMET00514 0.463 0.004 DBMET00486 | DBMET00486 | |
| 0.026 | 0.074 | 0.097 | Glutamate (mGluR8) antagonist | 0.073 0.004 DBMET00503 0.091 0.003 DBMET00506 0.096 0.003 DBMET00508 0.037 0.022 DBMET00514 0.097 0.003 DBMET00486 | DBMET00486 | |
| 0.026 | 0.082 | 0.436 | Neurokinin 2 agonist | 0.436 0.002 DBMET00506 0.057 0.014 DBMET00508 0.094 0.005 DBMET00486 | DBMET00506 | |
| 0.015 | 0.086 | 0.03 | Catechol O-methyltransferase inhibitor | 0.03 0.028 DBMET00514 | DBMET00514 | |
| 0.06 | 0.137 | 0.391 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.354 0.004 DBMET00503 0.355 0.004 DBMET00506 0.375 0.004 DBMET00508 0.186 0.018 DBMET00514 0.391 0.004 DBMET00486 | DBMET00486 | |
| 0.037 | 0.119 | 0.521 | Angiotensin-converting enzyme inhibitor | 0.488 0.002 DBMET00503 0.158 0.005 DBMET00506 0.521 0.002 DBMET00508 0.22 0.004 DBMET00486 | DBMET00508 | |
| 0.024 | 0.111 | 0.039 | Phenylethanolamine N methyltransferase inhibitor | 0.039 0.032 DBMET00506 | DBMET00506 | |
| 0.019 | 0.112 | 0.05 | Adenosine A2b receptor antagonist | 0.05 0.034 DBMET00514 | DBMET00514 | |
| 0.165 | 0.26 | 0.423 | Interleukin 2 agonist | 0.423 0.021 DBMET00503 0.4 0.027 DBMET00506 0.407 0.025 DBMET00508 0.262 0.106 DBMET00514 0.415 0.023 DBMET00486 | DBMET00503 | |
| 0.037 | 0.134 | 0.26 | Sirtuin 1 inhibitor | 0.116 0.016 DBMET00503 0.26 0.003 DBMET00506 0.147 0.007 DBMET00508 0.067 0.048 DBMET00514 0.163 0.005 DBMET00486 | DBMET00506 | |
| 0.096 | 0.197 | 0.738 | Interleukin antagonist | 0.738 0.004 DBMET00503 0.396 0.031 DBMET00506 0.653 0.008 DBMET00508 0.352 0.038 DBMET00486 | DBMET00503 | |
| 0.025 | 0.141 | 0.293 | Aminopeptidase microsomal inhibitor | 0.293 0.003 DBMET00503 0.166 0.005 DBMET00506 0.227 0.004 DBMET00508 0.158 0.006 DBMET00486 | DBMET00503 | |
| 0.017 | 0.138 | 0.273 | Aminopeptidase N inhibitor | 0.273 0.003 DBMET00503 0.143 0.006 DBMET00506 0.206 0.004 DBMET00508 0.136 0.007 DBMET00486 | DBMET00503 | |
| 0.017 | 0.14 | 0.084 | Thymidylate synthase inhibitor | 0.075 0.009 DBMET00503 0.084 0.006 DBMET00506 0.083 0.006 DBMET00508 0.045 0.034 DBMET00514 0.081 0.007 DBMET00486 | DBMET00506 | |
| 0.141 | 0.266 | 0.383 | Antithrombotic | 0.307 0.084 DBMET00503 0.383 0.054 DBMET00506 0.343 0.067 DBMET00508 0.355 0.063 DBMET00514 0.323 0.075 DBMET00486 | DBMET00506 | |
| 0.085 | 0.214 | 0.152 | Platelet adhesion inhibitor | 0.152 0.104 DBMET00514 | DBMET00514 | |
| 0.091 | 0.225 | 0.21 | Interleukin 6 antagonist | 0.21 0.035 DBMET00506 | DBMET00506 | |
| 0.114 | 0.248 | 0.291 | Hypoglycemic | 0.195 0.117 DBMET00503 0.291 0.056 DBMET00506 0.172 0.144 DBMET00508 | DBMET00506 | |
| 0.005 | 0.141 | 0.06 | Growth hormone releasing factor antagonist | 0.021 0.018 DBMET00503 0.06 0.005 DBMET00506 0.024 0.016 DBMET00508 0.025 0.016 DBMET00486 | DBMET00506 | |
| 0.022 | 0.159 | 0.118 | Selectin antagonist | 0.118 0.023 DBMET00503 0.102 0.027 DBMET00506 0.087 0.033 DBMET00508 0.083 0.035 DBMET00486 | DBMET00503 | |
| 0.029 | 0.168 | 0.249 | Bombesin 1 receptor agonist | 0.249 0.004 DBMET00506 0.068 0.033 DBMET00508 0.111 0.015 DBMET00486 | DBMET00506 | |
| 0.079 | 0.221 | 0.15 | Hexokinase inhibitor | 0.15 0.079 DBMET00514 | DBMET00514 | |
| 0.039 | 0.183 | 0.068 | Lipocortins synthesis agonist | 0.068 0.024 DBMET00506 | DBMET00506 | |
| 0.103 | 0.247 | 0.493 | Antioxidant | 0.493 0.021 DBMET00503 0.261 0.078 DBMET00506 0.385 0.038 DBMET00508 0.389 0.037 DBMET00486 | DBMET00503 | |
| 0.024 | 0.172 | 0.082 | Cytokine production stimulant | 0.082 0.005 DBMET00506 0.053 0.022 DBMET00486 | DBMET00506 | |
| 0.003 | 0.151 | 0.45 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.183 0.003 DBMET00503 0.031 0.005 DBMET00506 0.45 0.002 DBMET00508 0.026 0.005 DBMET00486 | DBMET00508 | |
| 0.005 | 0.159 | 0.1 | Aminopeptidase P inhibitor | 0.1 0.002 DBMET00503 0.024 0.016 DBMET00506 0.06 0.003 DBMET00508 0.025 0.014 DBMET00486 | DBMET00503 | |
| 0.069 | 0.223 | 0.152 | Protein kinase stimulant | 0.152 0.067 DBMET00503 0.109 0.106 DBMET00506 0.14 0.075 DBMET00508 0.138 0.077 DBMET00514 0.115 0.098 DBMET00486 | DBMET00503 | |
| 0.004 | 0.162 | 0.074 | Human T-cell leukemia virus type I protease inhibitor | 0.074 0.003 DBMET00506 0.024 0.011 DBMET00486 | DBMET00506 | |
| 0.165 | 0.33 | 0.251 | Apoptosis agonist | 0.251 0.213 DBMET00514 0.243 0.223 DBMET00486 | DBMET00514 | |
| 0.002 | 0.184 | 0.067 | Glucagon agonist | 0.067 0.004 DBMET00506 0.014 0.011 DBMET00508 0.018 0.009 DBMET00486 | DBMET00506 | |
| 0.009 | 0.2 | 0.044 | Guanylate cyclase inhibitor | 0.044 0.028 DBMET00503 | DBMET00503 | |
| 0.007 | 0.201 | 0.243 | Geranylgeranyltransferase I inhibitor | 0.243 0.002 DBMET00503 0.114 0.004 DBMET00506 0.204 0.003 DBMET00508 0.033 0.007 DBMET00486 | DBMET00503 | |
| 0.009 | 0.215 | 0.147 | Phosphorylase inhibitor | 0.147 0.007 DBMET00503 0.062 0.024 DBMET00508 0.039 0.038 DBMET00514 0.044 0.034 DBMET00486 | DBMET00503 | |
| 0.013 | 0.219 | 0.327 | Mannosidase inhibitor | 0.327 0.002 DBMET00503 0.075 0.01 DBMET00506 0.188 0.003 DBMET00508 0.091 0.007 DBMET00486 | DBMET00503 | |
| 0.085 | 0.304 | 0.195 | Cardiotonic | 0.168 0.154 DBMET00506 0.195 0.124 DBMET00514 | DBMET00514 | |
| 0.012 | 0.232 | 0.386 | Endothelin-converting enzyme inhibitor | 0.386 0.003 DBMET00503 0.079 0.018 DBMET00506 0.259 0.004 DBMET00508 0.053 0.029 DBMET00486 | DBMET00503 | |
| 0.059 | 0.281 | 0.142 | MAP3K9 inhibitor | 0.142 0.072 DBMET00514 | DBMET00514 | |
| 0.003 | 0.225 | 0.442 | Neutral endopeptidase inhibitor | 0.442 0.002 DBMET00503 0.072 0.005 DBMET00506 0.296 0.003 DBMET00508 0.097 0.005 DBMET00486 | DBMET00503 | |
| 0.123 | 0.35 | 0.594 | Histamine release inhibitor | 0.334 0.107 DBMET00503 0.594 0.011 DBMET00506 0.389 0.081 DBMET00508 0.482 0.036 DBMET00486 | DBMET00506 | |
| 0.048 | 0.275 | 0.137 | Toll-Like receptor 4 antagonist | 0.137 0.029 DBMET00503 0.098 0.073 DBMET00508 0.129 0.035 DBMET00514 | DBMET00503 | |
| 0.022 | 0.25 | 0.123 | Glucose-6-phosphate translocase inhibitor | 0.123 0.004 DBMET00506 0.072 0.015 DBMET00486 | DBMET00506 | |
| 0.069 | 0.297 | 0.161 | Spasmolytic | 0.161 0.153 DBMET00506 | DBMET00506 | |
| 0.001 | 0.244 | 0.196 | Glutamate (mGluR6) agonist | 0.114 0.001 DBMET00503 0.1 0.002 DBMET00506 0.104 0.002 DBMET00508 0.196 0.001 DBMET00486 | DBMET00486 | |
| 0.015 | 0.267 | 0.324 | Alpha-mannosidase inhibitor | 0.324 0.002 DBMET00503 0.088 0.009 DBMET00506 0.173 0.004 DBMET00508 0.101 0.006 DBMET00486 | DBMET00503 | |
| 0.049 | 0.305 | 0.119 | Acetylcholine M1 receptor antagonist | 0.119 0.11 DBMET00506 | DBMET00506 | |
| 0.004 | 0.266 | 0.021 | Telomerase stimulant | 0.021 0.007 DBMET00503 0.018 0.011 DBMET00506 0.019 0.009 DBMET00508 0.019 0.009 DBMET00486 | DBMET00503 | |
| 0.025 | 0.3 | 0.089 | Interferon agonist | 0.089 0.04 DBMET00503 0.085 0.044 DBMET00508 0.072 0.066 DBMET00486 | DBMET00503 | |
| 0.033 | 0.31 | 0.599 | Chelator | 0.599 0.004 DBMET00503 0.222 0.021 DBMET00506 0.456 0.005 DBMET00508 0.213 0.022 DBMET00486 | DBMET00503 | |
| 0.026 | 0.304 | 0.063 | Interferon inducer | 0.063 0.046 DBMET00503 0.061 0.051 DBMET00508 | DBMET00503 | |
| 0.088 | 0.37 | 0.351 | Cholesterol antagonist | 0.351 0.064 DBMET00503 0.255 0.121 DBMET00506 0.328 0.075 DBMET00508 0.258 0.119 DBMET00514 0.291 0.097 DBMET00486 | DBMET00503 | |
| 0.034 | 0.321 | 0.098 | Phosphodiesterase I inhibitor | 0.098 0.046 DBMET00503 | DBMET00503 | |
| 0.005 | 0.298 | 0.101 | Prostacyclin antagonist | 0.041 0.017 DBMET00503 0.084 0.005 DBMET00506 0.038 0.019 DBMET00508 0.101 0.005 DBMET00486 | DBMET00486 | |
| 0.057 | 0.353 | 0.12 | Factor V inhibitor | 0.12 0.039 DBMET00503 0.114 0.045 DBMET00506 0.118 0.04 DBMET00508 0.118 0.04 DBMET00486 | DBMET00503 | |
| 0.03 | 0.328 | 0.155 | Anabolic | 0.155 0.015 DBMET00503 0.107 0.053 DBMET00506 0.15 0.018 DBMET00508 0.115 0.044 DBMET00486 | DBMET00503 | |
| 0.038 | 0.336 | 0.238 | Nav1.4 sodium channel blocker | 0.13 0.044 DBMET00503 0.238 0.011 DBMET00506 0.118 0.054 DBMET00508 0.127 0.047 DBMET00486 | DBMET00506 | |
| 0.026 | 0.323 | 0.159 | Ornithine decarboxylase inhibitor | 0.129 0.02 DBMET00503 0.154 0.01 DBMET00506 0.146 0.012 DBMET00508 0.159 0.009 DBMET00486 | DBMET00486 | |
| 0.008 | 0.324 | 0.045 | Somatostatin 1 antagonist | 0.045 0.023 DBMET00503 0.038 0.027 DBMET00508 | DBMET00503 | |
| 0.057 | 0.375 | 0.154 | Hemostatic | 0.154 0.063 DBMET00503 0.119 0.116 DBMET00508 | DBMET00503 | |
| 0.013 | 0.332 | 0.165 | Cholecystokinin B agonist | 0.034 0.032 DBMET00503 0.165 0.005 DBMET00506 0.042 0.021 DBMET00508 0.056 0.013 DBMET00486 | DBMET00506 | |
| 0.031 | 0.356 | 0.517 | Thrombolytic | 0.517 0.005 DBMET00503 0.466 0.006 DBMET00506 0.466 0.006 DBMET00508 0.144 0.087 DBMET00514 0.47 0.006 DBMET00486 | DBMET00503 | |
| 0.028 | 0.36 | 0.289 | Histone deacetylase class III inhibitor | 0.289 0.006 DBMET00506 0.105 0.085 DBMET00508 0.162 0.035 DBMET00486 | DBMET00506 | |
| 0.048 | 0.381 | 0.158 | Nitric oxide antagonist | 0.127 0.124 DBMET00506 0.158 0.089 DBMET00486 | DBMET00486 | |
| 0.013 | 0.351 | 0.842 | Phenylalanine 4-hydroxylase inhibitor | 0.842 0.001 DBMET00503 0.663 0.002 DBMET00506 0.705 0.001 DBMET00508 0.616 0.002 DBMET00486 | DBMET00503 | |
| 0.01 | 0.348 | 0.181 | Membrane dipeptidase inhibitor | 0.181 0.001 DBMET00503 0.139 0.002 DBMET00506 0.155 0.002 DBMET00508 0.16 0.002 DBMET00486 | DBMET00503 | |
| 0.011 | 0.352 | 0.111 | Histone deacetylase SIRT2 inhibitor | 0.111 0.021 DBMET00506 | DBMET00506 | |
| 0.004 | 0.349 | 0.047 | Kainate receptor 3 antagonist | 0.016 0.014 DBMET00503 0.036 0.005 DBMET00506 0.043 0.004 DBMET00508 0.047 0.004 DBMET00486 | DBMET00486 | |
| 0.045 | 0.39 | 0.45 | Histone deacetylase SIRT1 inhibitor | 0.157 0.056 DBMET00503 0.45 0.004 DBMET00506 0.21 0.027 DBMET00508 0.269 0.013 DBMET00486 | DBMET00506 | |
| 0.015 | 0.364 | 0.1 | Nitric oxide donor | 0.072 0.031 DBMET00506 0.1 0.008 DBMET00486 | DBMET00486 | |
| 0.001 | 0.35 | 0.236 | Aminopeptidase A inhibitor | 0.236 0.001 DBMET00503 0.11 0.002 DBMET00506 0.236 0.001 DBMET00508 0.077 0.002 DBMET00486 | DBMET00508 | |
| 0.007 | 0.358 | 0.03 | Tryptophan hydroxylase 1 inhibitor | 0.03 0.004 DBMET00503 0.026 0.004 DBMET00506 0.026 0.004 DBMET00508 0.026 0.004 DBMET00486 | DBMET00503 | |
| 0.016 | 0.376 | 0.051 | Cathepsin F inhibitor | 0.051 0.011 DBMET00506 | DBMET00506 | |
| 0.025 | 0.39 | 0.474 | Psychostimulant | 0.166 0.103 DBMET00503 0.474 0.013 DBMET00506 0.277 0.049 DBMET00508 0.438 0.017 DBMET00486 | DBMET00506 | |
| 0.031 | 0.397 | 0.216 | Cathepsin H inhibitor | 0.142 0.052 DBMET00503 0.216 0.019 DBMET00506 0.155 0.043 DBMET00508 0.172 0.033 DBMET00486 | DBMET00506 | |
| 0.006 | 0.374 | 0.074 | Bradykinin B2 receptor agonist | 0.074 0.004 DBMET00503 0.025 0.024 DBMET00506 0.045 0.009 DBMET00508 0.027 0.021 DBMET00486 | DBMET00503 | |
| 0.013 | 0.388 | 0.161 | Glutamate (mGluR8) agonist | 0.129 0.002 DBMET00503 0.147 0.002 DBMET00506 0.151 0.002 DBMET00508 0.161 0.002 DBMET00486 | DBMET00486 | |
| 0.004 | 0.387 | 0.626 | Leukotriene A4 hydrolase inhibitor | 0.611 0.003 DBMET00503 0.163 0.005 DBMET00506 0.626 0.003 DBMET00508 0.386 0.004 DBMET00486 | DBMET00508 | |
| 0.008 | 0.399 | 0.11 | Carboxypeptidase B inhibitor | 0.11 0.003 DBMET00503 0.048 0.008 DBMET00506 0.101 0.003 DBMET00508 0.069 0.004 DBMET00486 | DBMET00503 | |
| 0.003 | 0.397 | 0.14 | Angiotensin-converting enzyme 2 inhibitor | 0.14 0.003 DBMET00503 0.017 0.013 DBMET00506 0.099 0.003 DBMET00508 0.018 0.011 DBMET00486 | DBMET00503 | |
| 0.033 | 0.43 | 0.35 | Cell wall synthesis inhibitor | 0.223 0.022 DBMET00503 0.258 0.014 DBMET00506 0.194 0.032 DBMET00508 0.159 0.057 DBMET00514 0.35 0.008 DBMET00486 | DBMET00486 | |
| 0.021 | 0.437 | 0.188 | Somatostatin 1 agonist | 0.188 0.008 DBMET00503 0.073 0.061 DBMET00506 0.141 0.016 DBMET00508 0.079 0.052 DBMET00486 | DBMET00503 | |
| 0.011 | 0.427 | 0.845 | Histidine decarboxylase inhibitor | 0.845 0.001 DBMET00503 0.409 0.004 DBMET00506 0.685 0.001 DBMET00508 0.512 0.003 DBMET00486 | DBMET00503 | |
| 0.013 | 0.439 | 0.069 | Glucose-6-phosphate isomerase inhibitor | 0.069 0.013 DBMET00503 0.062 0.017 DBMET00506 0.067 0.014 DBMET00508 0.067 0.014 DBMET00486 | DBMET00503 | |
| 0.008 | 0.436 | 0.162 | Glutamate (mGluR3) agonist | 0.061 0.004 DBMET00503 0.162 0.001 DBMET00506 0.085 0.003 DBMET00508 0.114 0.002 DBMET00486 | DBMET00506 | |
| 0.003 | 0.434 | 0.398 | Lysine carboxypeptidase inhibitor | 0.331 0.001 DBMET00503 0.171 0.002 DBMET00506 0.398 0.001 DBMET00508 0.262 0.002 DBMET00486 | DBMET00508 | |
| 0.034 | 0.467 | 0.489 | Free radical scavenger | 0.489 0.017 DBMET00503 0.253 0.067 DBMET00506 0.424 0.025 DBMET00508 0.352 0.038 DBMET00486 | DBMET00503 | |
| 0.008 | 0.443 | 0.152 | Glucagon-like peptide 1 agonist | 0.103 0.02 DBMET00503 0.152 0.008 DBMET00506 0.103 0.02 DBMET00508 0.108 0.018 DBMET00486 | DBMET00506 | |
| 0.01 | 0.449 | 0.97 | Glutamate decarboxylase inhibitor | 0.97 0.001 DBMET00503 0.589 0.002 DBMET00506 0.968 0.001 DBMET00508 0.85 0.001 DBMET00486 | DBMET00503 | |
| 0.01 | 0.462 | 0.075 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.075 0.056 DBMET00503 | DBMET00503 | |
| 0.022 | 0.481 | 0.263 | Glutamate (mGluR6) antagonist | 0.176 0.003 DBMET00503 0.22 0.003 DBMET00506 0.209 0.003 DBMET00508 0.263 0.002 DBMET00486 | DBMET00486 | |
| 0.023 | 0.483 | 0.508 | Alpha-N-acetylglucosaminidase inhibitor | 0.508 0.005 DBMET00503 0.356 0.011 DBMET00506 0.397 0.009 DBMET00508 0.397 0.009 DBMET00486 | DBMET00503 | |
| 0.023 | 0.486 | 0.111 | Xanthine oxidase inhibitor | 0.111 0.052 DBMET00503 0.094 0.066 DBMET00506 0.089 0.074 DBMET00508 | DBMET00503 | |
| 0.013 | 0.482 | 0.065 | Cathepsin D inhibitor | 0.052 0.04 DBMET00503 0.065 0.031 DBMET00506 0.05 0.041 DBMET00486 | DBMET00506 | |
| 0.001 | 0.474 | 0.053 | Carboxypeptidase B2 inhibitor | 0.053 0.002 DBMET00503 0.031 0.003 DBMET00508 0.019 0.004 DBMET00486 | DBMET00503 | |
| 0.019 | 0.497 | 0.083 | Parathyroid hormone antagonist | 0.083 0.004 DBMET00506 0.053 0.018 DBMET00486 | DBMET00506 | |
| 0.03 | 0.511 | 0.341 | Cyclooxygenase 3 inhibitor | 0.146 0.052 DBMET00503 0.341 0.005 DBMET00506 0.185 0.025 DBMET00508 0.306 0.006 DBMET00486 | DBMET00506 | |
| 0.019 | 0.502 | 0.306 | Lipid peroxidase inhibitor | 0.306 0.018 DBMET00503 0.143 0.073 DBMET00506 0.251 0.027 DBMET00508 0.183 0.049 DBMET00486 | DBMET00503 | |
| 0.006 | 0.492 | 0.037 | Growth factor receptor-bound protein 2 antagonist | 0.034 0.027 DBMET00503 0.037 0.02 DBMET00506 | DBMET00506 | |
| 0.005 | 0.5 | 0.028 | Vanilloid 2 agonist | 0.024 0.02 DBMET00503 0.026 0.016 DBMET00506 0.028 0.013 DBMET00508 0.028 0.013 DBMET00486 | DBMET00486 | |
| 0.008 | 0.506 | 0.205 | Growth hormone release inhibitor | 0.205 0.004 DBMET00503 0.078 0.01 DBMET00508 | DBMET00503 | |
| 0.023 | 0.525 | 0.252 | Interleukin 8 antagonist | 0.181 0.019 DBMET00503 0.252 0.005 DBMET00506 0.16 0.028 DBMET00508 0.131 0.049 DBMET00486 | DBMET00506 | |
| 0.004 | 0.51 | 0.042 | Kainate receptor 4 antagonist | 0.035 0.011 DBMET00506 0.04 0.009 DBMET00508 0.042 0.009 DBMET00486 | DBMET00486 | |
| 0.016 | 0.531 | 0.5 | GABA C receptor agonist | 0.5 0.004 DBMET00503 0.441 0.004 DBMET00506 0.485 0.004 DBMET00508 0.485 0.004 DBMET00486 | DBMET00503 | |
| 0.029 | 0.544 | 0.893 | Peroxidase inhibitor | 0.893 0.001 DBMET00503 0.591 0.005 DBMET00506 0.816 0.002 DBMET00508 0.683 0.003 DBMET00486 | DBMET00503 | |
| 0.019 | 0.535 | 0.237 | Bone formation stimulant | 0.237 0.028 DBMET00503 0.182 0.041 DBMET00506 0.232 0.028 DBMET00508 0.162 0.05 DBMET00486 | DBMET00503 | |
| 0.028 | 0.548 | 0.805 | Aldehyde oxidase inhibitor | 0.805 0.004 DBMET00503 0.541 0.027 DBMET00506 0.767 0.005 DBMET00508 0.41 0.045 DBMET00486 | DBMET00503 | |
| 0.024 | 0.545 | 0.548 | Amylase inhibitor | 0.548 0.005 DBMET00503 0.228 0.035 DBMET00506 0.312 0.017 DBMET00508 0.179 0.052 DBMET00486 | DBMET00503 | |
| 0.003 | 0.524 | 0.047 | Kainate receptor 5 antagonist | 0.039 0.007 DBMET00506 0.044 0.006 DBMET00508 0.047 0.005 DBMET00486 | DBMET00486 | |
| 0.017 | 0.54 | 0.439 | Pyruvate kinase inhibitor | 0.439 0.015 DBMET00503 0.18 0.093 DBMET00506 0.33 0.04 DBMET00508 0.188 0.088 DBMET00486 | DBMET00503 | |
| 0.017 | 0.543 | 0.126 | Vanilloid 2 antagonist | 0.126 0.004 DBMET00503 0.053 0.035 DBMET00506 0.112 0.004 DBMET00508 0.075 0.011 DBMET00486 | DBMET00503 | |
| 0.01 | 0.542 | 0.055 | Bombesin antagonist | 0.055 0.023 DBMET00506 | DBMET00506 | |
| 0.01 | 0.542 | 0.139 | Kainate receptor agonist | 0.108 0.003 DBMET00503 0.123 0.002 DBMET00506 0.133 0.002 DBMET00508 0.139 0.002 DBMET00486 | DBMET00486 | |
| 0.015 | 0.552 | 0.067 | Integrin alpha1beta1 antagonist | 0.046 0.011 DBMET00503 0.067 0.004 DBMET00506 0.043 0.015 DBMET00508 0.051 0.007 DBMET00486 | DBMET00506 | |
| 0.005 | 0.55 | 0.052 | Bombesin 1 receptor antagonist | 0.052 0.012 DBMET00506 | DBMET00506 | |
| 0.061 | 0.607 | 0.208 | Calcium channel activator | 0.208 0.201 DBMET00506 | DBMET00506 | |
| 0.02 | 0.57 | 0.193 | Triose-phosphate isomerase inhibitor | 0.169 0.015 DBMET00503 0.193 0.012 DBMET00506 0.147 0.021 DBMET00508 0.147 0.021 DBMET00486 | DBMET00506 | |
| 0.006 | 0.556 | 0.041 | Carbonic anhydrase I stimulant | 0.041 0.023 DBMET00503 0.035 0.029 DBMET00506 0.037 0.027 DBMET00508 0.04 0.024 DBMET00486 | DBMET00503 | |
| 0.009 | 0.565 | 0.418 | Aminopeptidase I inhibitor | 0.418 0.002 DBMET00503 0.213 0.006 DBMET00506 0.368 0.002 DBMET00508 0.229 0.005 DBMET00486 | DBMET00503 | |
| 0.013 | 0.59 | 0.131 | Protease inhibitor | 0.125 0.044 DBMET00506 0.089 0.075 DBMET00508 0.131 0.04 DBMET00486 | DBMET00486 | |
| 0.016 | 0.594 | 0.055 | Carbonic anhydrase II stimulant | 0.053 0.033 DBMET00503 0.051 0.037 DBMET00506 0.051 0.038 DBMET00508 0.055 0.031 DBMET00486 | DBMET00486 | |
| 0.004 | 0.595 | 0.064 | AMPA 2 receptor antagonist | 0.033 0.018 DBMET00503 0.062 0.009 DBMET00506 0.064 0.009 DBMET00508 0.06 0.009 DBMET00486 | DBMET00508 | |
| 0.018 | 0.613 | 0.077 | DNA helicase inhibitor | 0.077 0.012 DBMET00503 0.066 0.02 DBMET00506 0.065 0.021 DBMET00508 0.071 0.016 DBMET00486 | DBMET00503 | |
| 0.017 | 0.624 | 0.128 | Electrolyte absorption antagonist | 0.128 0.031 DBMET00503 0.087 0.079 DBMET00506 0.112 0.044 DBMET00508 0.099 0.059 DBMET00486 | DBMET00503 | |
| 0.005 | 0.611 | 0.173 | Opioid delta receptor antagonist | 0.173 0.015 DBMET00506 0.082 0.036 DBMET00508 0.088 0.033 DBMET00486 | DBMET00506 | |
| 0.066 | 0.675 | 0.208 | Nitric-oxide synthase stimulant | 0.208 0.076 DBMET00503 0.176 0.139 DBMET00506 0.18 0.129 DBMET00508 0.189 0.11 DBMET00486 | DBMET00503 | |
| 0.011 | 0.62 | 0.143 | Microtubule formation inhibitor | 0.111 0.072 DBMET00503 0.117 0.063 DBMET00506 0.143 0.041 DBMET00486 | DBMET00486 | |
| 0.001 | 0.624 | 0.037 | Ileal bile acid transport inhibitor | 0.037 0.004 DBMET00506 0.021 0.009 DBMET00486 | DBMET00506 | |
| 0.004 | 0.631 | 0.19 | Prostaglandin EP2 antagonist | 0.085 0.024 DBMET00506 0.19 0.007 DBMET00486 | DBMET00486 | |
| 0.001 | 0.631 | 0.038 | Neurokinin 1 agonist | 0.038 0.008 DBMET00506 0.02 0.014 DBMET00486 | DBMET00506 | |
| 0.054 | 0.691 | 0.149 | Ca2+-transporting ATPase inhibitor | 0.148 0.047 DBMET00503 0.145 0.056 DBMET00506 0.146 0.052 DBMET00508 0.149 0.044 DBMET00486 | DBMET00486 | |
| 0.004 | 0.643 | 0.058 | AMPA receptor agonist | 0.047 0.011 DBMET00503 0.058 0.006 DBMET00506 0.05 0.009 DBMET00508 0.053 0.008 DBMET00486 | DBMET00506 | |
| 0.007 | 0.647 | 0.267 | Erythropoietin receptor agonist | 0.039 0.029 DBMET00503 0.267 0.005 DBMET00506 0.037 0.032 DBMET00486 | DBMET00506 | |
| 0.014 | 0.654 | 0.15 | Glycine receptor agonist | 0.15 0.007 DBMET00503 0.121 0.012 DBMET00506 0.133 0.009 DBMET00508 0.136 0.009 DBMET00486 | DBMET00503 | |
| 0.045 | 0.685 | 0.303 | Sodium/bile acid cotransporter inhibitor | 0.214 0.169 DBMET00503 0.303 0.076 DBMET00506 0.227 0.154 DBMET00508 0.24 0.139 DBMET00486 | DBMET00506 | |
| 0.039 | 0.682 | 0.324 | Cyclophilin D inhibitor | 0.324 0.143 DBMET00506 | DBMET00506 | |
| 0.013 | 0.657 | 0.163 | Factor XII inhibitor | 0.163 0.01 DBMET00503 0.134 0.018 DBMET00506 0.133 0.018 DBMET00508 0.108 0.031 DBMET00486 | DBMET00503 | |
| 0.005 | 0.65 | 0.133 | AMPA 4 receptor antagonist | 0.072 0.007 DBMET00503 0.133 0.004 DBMET00506 0.099 0.005 DBMET00508 0.093 0.005 DBMET00486 | DBMET00506 | |
| 0.003 | 0.649 | 0.231 | Glutamate (mGluR3) antagonist | 0.13 0.004 DBMET00503 0.129 0.004 DBMET00506 0.231 0.003 DBMET00508 0.142 0.004 DBMET00486 | DBMET00508 | |
| 0.004 | 0.65 | 0.027 | Caspase 2 inhibitor | 0.027 0.026 DBMET00503 | DBMET00503 | |
| 0.004 | 0.65 | 0.168 | Alcohol oxidase inhibitor | 0.168 0.009 DBMET00503 0.102 0.018 DBMET00506 0.127 0.013 DBMET00508 0.127 0.013 DBMET00486 | DBMET00503 | |
| 0.004 | 0.654 | 0.033 | Opioid delta receptor agonist | 0.033 0.028 DBMET00506 | DBMET00506 | |
| 0.022 | 0.672 | 0.175 | Tumour necrosis factor alpha release inhibitor | 0.175 0.13 DBMET00486 | DBMET00486 | |
| 0.006 | 0.661 | 0.156 | Analgesic, opioid | 0.156 0.014 DBMET00503 0.108 0.027 DBMET00506 0.117 0.024 DBMET00508 0.1 0.031 DBMET00486 | DBMET00503 | |
| 0.001 | 0.661 | 0.031 | Carbonic anhydrase X inhibitor | 0.025 0.005 DBMET00503 0.027 0.005 DBMET00506 0.025 0.005 DBMET00508 0.031 0.004 DBMET00486 | DBMET00486 | |
| 0.001 | 0.661 | 0.031 | Carbonic anhydrase VIII inhibitor | 0.025 0.005 DBMET00503 0.027 0.005 DBMET00506 0.025 0.005 DBMET00508 0.031 0.004 DBMET00486 | DBMET00486 | |
| 0.006 | 0.667 | 0.441 | Diuretic | 0.441 0.011 DBMET00503 0.273 0.027 DBMET00506 0.323 0.019 DBMET00508 0.177 0.056 DBMET00486 | DBMET00503 | |
| 0.024 | 0.693 | 0.151 | Interferon gamma antagonist | 0.135 0.101 DBMET00503 0.151 0.077 DBMET00506 0.146 0.084 DBMET00508 0.151 0.076 DBMET00486 | DBMET00486 | |
| 0.006 | 0.686 | 0.612 | NMDA receptor agonist | 0.612 0.002 DBMET00503 0.462 0.002 DBMET00506 0.535 0.002 DBMET00508 0.435 0.002 DBMET00486 | DBMET00503 | |
| 0.004 | 0.69 | 0.053 | Opioid mu receptor agonist | 0.053 0.027 DBMET00506 | DBMET00506 | |
| 0.002 | 0.691 | 0.236 | Glutamate (mGluR1a) agonist | 0.17 0.003 DBMET00503 0.202 0.002 DBMET00506 0.184 0.002 DBMET00508 0.236 0.002 DBMET00486 | DBMET00486 | |
| 0.009 | 0.699 | 0.127 | Glutamate (mGluR4) antagonist | 0.083 0.008 DBMET00503 0.127 0.004 DBMET00506 0.098 0.005 DBMET00508 0.104 0.005 DBMET00486 | DBMET00506 | |
| 0.003 | 0.695 | 0.093 | Complement C3a chemotactic receptor antagonist | 0.083 0.013 DBMET00503 0.075 0.016 DBMET00506 0.076 0.015 DBMET00508 0.093 0.01 DBMET00486 | DBMET00486 | |
| 0.005 | 0.697 | 0.061 | Carbonic anhydrase VA inhibitor | 0.061 0.058 DBMET00503 | DBMET00503 | |
| 0.003 | 0.699 | 0.027 | Somatostatin 5 antagonist | 0.027 0.025 DBMET00503 | DBMET00503 | |
| 0.004 | 0.704 | 0.144 | Opioid mu receptor antagonist | 0.144 0.019 DBMET00506 0.063 0.051 DBMET00508 0.088 0.036 DBMET00486 | DBMET00506 | |
| 0.002 | 0.706 | 0.127 | Endothelial nitric-oxide synthase inhibitor | 0.127 0.004 DBMET00506 0.033 0.019 DBMET00508 0.044 0.011 DBMET00486 | DBMET00506 | |
| 0.005 | 0.716 | 0.048 | Dipeptidyl peptidase inhibitor | 0.048 0.046 DBMET00506 | DBMET00506 | |
| 0.011 | 0.724 | 0.336 | Glutathione S-transferase inhibitor | 0.256 0.004 DBMET00503 0.295 0.003 DBMET00506 0.277 0.003 DBMET00508 0.336 0.003 DBMET00486 | DBMET00486 | |
| 0.003 | 0.717 | 0.04 | Dipeptidyl peptidase II inhibitor | 0.04 0.015 DBMET00506 0.033 0.021 DBMET00486 | DBMET00506 | |
| 0.06 | 0.775 | 0.482 | 5 Hydroxytryptamine uptake stimulant | 0.394 0.015 DBMET00503 0.482 0.005 DBMET00506 0.378 0.019 DBMET00508 0.421 0.011 DBMET00486 | DBMET00506 | |
| 0.005 | 0.722 | 0.461 | Nitric-oxide synthase inhibitor | 0.179 0.014 DBMET00503 0.377 0.004 DBMET00506 0.19 0.011 DBMET00508 0.461 0.003 DBMET00486 | DBMET00486 | |
| 0.017 | 0.739 | 0.104 | Lanosterol 14 alpha demethylase inhibitor | 0.088 0.075 DBMET00503 0.104 0.05 DBMET00506 0.091 0.07 DBMET00486 | DBMET00506 | |
| 0.004 | 0.731 | 0.069 | Collagenase inhibitor | 0.069 0.01 DBMET00503 0.051 0.03 DBMET00506 0.059 0.017 DBMET00508 0.052 0.029 DBMET00486 | DBMET00503 | |
| 0.003 | 0.732 | 0.036 | Calcitonin receptor agonist | 0.036 0.022 DBMET00503 0.03 0.027 DBMET00506 0.033 0.024 DBMET00508 0.033 0.024 DBMET00486 | DBMET00503 | |
| 0.007 | 0.736 | 0.134 | Cell adhesion molecule inhibitor | 0.073 0.063 DBMET00503 0.134 0.019 DBMET00506 0.071 0.069 DBMET00508 0.097 0.037 DBMET00486 | DBMET00506 | |
| 0.003 | 0.733 | 0.192 | GP IIb/IIIa receptor antagonist | 0.192 0.007 DBMET00503 0.084 0.021 DBMET00506 0.146 0.011 DBMET00508 0.068 0.025 DBMET00486 | DBMET00503 | |
| 0.006 | 0.738 | 0.024 | Complement factor 1s inhibitor | 0.024 0.022 DBMET00506 | DBMET00506 | |
| 0.003 | 0.736 | 0.345 | Kinesin antagonist | 0.292 0.003 DBMET00503 0.054 0.015 DBMET00506 0.044 0.019 DBMET00508 0.345 0.002 DBMET00486 | DBMET00486 | |
| 0.003 | 0.736 | 0.345 | Kinesin-like protein 1 inhibitor | 0.292 0.003 DBMET00503 0.054 0.015 DBMET00506 0.044 0.019 DBMET00508 0.345 0.002 DBMET00486 | DBMET00486 | |
| 0.043 | 0.776 | 0.514 | Tyrosine 3 hydroxylase inhibitor | 0.45 0.005 DBMET00503 0.514 0.004 DBMET00506 0.441 0.005 DBMET00508 0.441 0.005 DBMET00486 | DBMET00506 | |
| 0.01 | 0.743 | 0.104 | M18 aspartyl aminopeptidase inhibitor | 0.104 0.087 DBMET00503 | DBMET00503 | |
| 0.017 | 0.752 | 0.065 | Caspase 9 inhibitor | 0.065 0.038 DBMET00506 | DBMET00506 | |
| 0.008 | 0.745 | 0.052 | Neurotensin receptor antagonist | 0.052 0.027 DBMET00503 0.04 0.037 DBMET00506 0.046 0.031 DBMET00508 0.043 0.034 DBMET00486 | DBMET00503 | |
| 0.003 | 0.743 | 0.126 | Glutamate (mGluR4) agonist | 0.07 0.007 DBMET00503 0.091 0.005 DBMET00506 0.126 0.004 DBMET00508 0.111 0.004 DBMET00486 | DBMET00508 | |
| 0.007 | 0.749 | 0.143 | Neurotrophic factor | 0.143 0.065 DBMET00506 0.139 0.07 DBMET00486 | DBMET00506 | |
| 0.007 | 0.75 | 0.049 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.049 0.016 DBMET00503 0.04 0.031 DBMET00506 0.042 0.027 DBMET00508 0.044 0.024 DBMET00486 | DBMET00503 | |
| 0.013 | 0.759 | 0.11 | Interleukin 1 antagonist | 0.11 0.105 DBMET00486 | DBMET00486 | |
| 0.003 | 0.751 | 0.07 | Vitronectin receptor antagonist | 0.07 0.005 DBMET00503 0.038 0.008 DBMET00508 | DBMET00503 | |
| 0.009 | 0.759 | 0.126 | GABA C receptor rho-1 antagonist | 0.126 0.035 DBMET00503 0.103 0.058 DBMET00506 0.116 0.044 DBMET00508 0.116 0.044 DBMET00486 | DBMET00503 | |
| 0.003 | 0.762 | 0.547 | Catalase inhibitor | 0.547 0.001 DBMET00503 0.325 0.005 DBMET00506 0.51 0.002 DBMET00508 0.416 0.003 DBMET00486 | DBMET00503 | |
| 0.003 | 0.763 | 0.087 | Cholecystokinin agonist | 0.087 0.005 DBMET00506 | DBMET00506 | |
| 0.005 | 0.767 | 0.278 | Glutamate (mGluR group III) agonist | 0.165 0.004 DBMET00503 0.185 0.004 DBMET00506 0.194 0.004 DBMET00508 0.278 0.003 DBMET00486 | DBMET00486 | |
| 0.004 | 0.767 | 0.049 | Glutamate (mGluR group II) agonist | 0.049 0.016 DBMET00506 | DBMET00506 | |
| 0.007 | 0.77 | 0.171 | GABA C receptor antagonist | 0.171 0.021 DBMET00503 0.144 0.033 DBMET00506 0.162 0.024 DBMET00508 0.162 0.024 DBMET00486 | DBMET00503 | |
| 0.004 | 0.767 | 0.507 | Inducible nitric-oxide synthase inhibitor | 0.204 0.008 DBMET00503 0.364 0.004 DBMET00506 0.221 0.006 DBMET00508 0.507 0.003 DBMET00486 | DBMET00486 | |
| 0.003 | 0.77 | 0.375 | Porphobilinogen synthase inhibitor | 0.375 0.004 DBMET00503 0.197 0.013 DBMET00506 0.316 0.005 DBMET00508 0.13 0.025 DBMET00486 | DBMET00503 | |
| 0.005 | 0.772 | 0.119 | GABA aminotransferase inhibitor | 0.116 0.018 DBMET00503 0.106 0.023 DBMET00506 0.111 0.02 DBMET00508 0.119 0.016 DBMET00486 | DBMET00486 | |
| 0.021 | 0.789 | 0.794 | Superoxide dismutase inhibitor | 0.723 0.004 DBMET00503 0.794 0.003 DBMET00506 0.793 0.003 DBMET00508 0.698 0.004 DBMET00486 | DBMET00506 | |
| 0.007 | 0.776 | 0.172 | Creatine kinase inhibitor | 0.172 0.016 DBMET00503 0.138 0.03 DBMET00506 0.154 0.022 DBMET00508 0.154 0.022 DBMET00486 | DBMET00503 | |
| 0.005 | 0.776 | 0.112 | Glutamate (mGluR group III) antagonist | 0.069 0.01 DBMET00503 0.112 0.005 DBMET00506 0.084 0.007 DBMET00508 0.097 0.005 DBMET00486 | DBMET00506 | |
| 0.007 | 0.778 | 0.194 | Hypolipemic | 0.194 0.099 DBMET00506 0.174 0.115 DBMET00486 | DBMET00506 | |
| 0.01 | 0.782 | 0.035 | Calcium-independent phospholipase A2 inhibitor | 0.035 0.022 DBMET00486 | DBMET00486 | |
| 0.01 | 0.783 | 0.248 | Cell adhesion inhibitor | 0.227 0.018 DBMET00503 0.248 0.015 DBMET00506 0.176 0.033 DBMET00508 0.167 0.037 DBMET00486 | DBMET00506 | |
| 0.012 | 0.787 | 0.19 | Carbonic anhydrase III inhibitor | 0.19 0.018 DBMET00503 0.16 0.025 DBMET00508 0.096 0.067 DBMET00486 | DBMET00503 | |
| 0.007 | 0.782 | 0.169 | Opioid antagonist | 0.169 0.021 DBMET00506 0.085 0.063 DBMET00508 0.101 0.047 DBMET00486 | DBMET00506 | |
| 0.007 | 0.783 | 0.088 | Carbonic anhydrase XIII inhibitor | 0.088 0.044 DBMET00503 0.068 0.06 DBMET00508 | DBMET00503 | |
| 0.003 | 0.78 | 0.035 | Glutamate (mGluR2) agonist | 0.035 0.021 DBMET00506 | DBMET00506 | |
| 0.008 | 0.784 | 0.28 | Toll-Like receptor 2 antagonist | 0.187 0.03 DBMET00503 0.203 0.022 DBMET00506 0.178 0.035 DBMET00508 0.28 0.006 DBMET00486 | DBMET00486 | |
| 0.013 | 0.792 | 0.27 | Transcription factor STAT inhibitor | 0.27 0.073 DBMET00506 | DBMET00506 | |
| 0.002 | 0.783 | 0.116 | Geranylgeranyltransferase inhibitor | 0.095 0.003 DBMET00503 0.088 0.003 DBMET00506 0.116 0.003 DBMET00508 0.037 0.007 DBMET00486 | DBMET00508 | |
| 0.007 | 0.788 | 0.326 | Anticoagulant | 0.303 0.028 DBMET00503 0.326 0.024 DBMET00506 0.257 0.037 DBMET00508 0.296 0.029 DBMET00486 | DBMET00506 | |
| 0.003 | 0.785 | 0.103 | Aconitate hydratase inhibitor | 0.103 0.008 DBMET00503 0.089 0.011 DBMET00506 0.1 0.008 DBMET00508 0.1 0.008 DBMET00486 | DBMET00503 | |
| 0.011 | 0.795 | 0.088 | Granulocyte macrophage colony stimulating factor agonist | 0.088 0.056 DBMET00503 0.08 0.074 DBMET00508 0.08 0.074 DBMET00486 | DBMET00503 | |
| 0.001 | 0.786 | 0.037 | Dihydropteroate synthase inhibitor | 0.037 0.03 DBMET00503 | DBMET00503 | |
| 0.027 | 0.814 | 0.116 | Glutamate release inhibitor | 0.087 0.07 DBMET00503 0.116 0.025 DBMET00506 0.09 0.061 DBMET00486 | DBMET00506 | |
| 0.002 | 0.789 | 0.027 | Lysophosphatidic acid receptor 1 agonist | 0.027 0.014 DBMET00503 0.026 0.015 DBMET00506 0.027 0.014 DBMET00508 0.024 0.02 DBMET00486 | DBMET00508 | |
| 0.026 | 0.813 | 0.355 | 5 Hydroxytryptamine release inhibitor | 0.355 0.111 DBMET00503 0.321 0.143 DBMET00506 0.326 0.137 DBMET00508 0.354 0.112 DBMET00486 | DBMET00503 | |
| 0.009 | 0.798 | 0.546 | Succinate dehydrogenase inhibitor | 0.546 0.003 DBMET00503 0.269 0.017 DBMET00506 0.532 0.003 DBMET00508 0.288 0.013 DBMET00486 | DBMET00503 | |
| 0.026 | 0.816 | 0.234 | GABA C receptor rho-3 antagonist | 0.234 0.169 DBMET00503 0.204 0.202 DBMET00508 0.204 0.202 DBMET00486 | DBMET00503 | |
| 0.009 | 0.8 | 0.191 | DOPA decarboxylase inhibitor | 0.191 0.008 DBMET00503 0.176 0.011 DBMET00506 0.179 0.011 DBMET00508 0.189 0.008 DBMET00486 | DBMET00503 | |
| 0.004 | 0.798 | 0.102 | Glutamate (mGluR7) antagonist | 0.098 0.012 DBMET00503 0.094 0.014 DBMET00506 0.102 0.009 DBMET00508 0.102 0.009 DBMET00486 | DBMET00486 | |
| 0.004 | 0.799 | 0.077 | Histone deacetylase SIRT3 inhibitor | 0.077 0.02 DBMET00506 | DBMET00506 | |
| 0.001 | 0.803 | 0.092 | Sirtuin 2 inhibitor | 0.092 0.005 DBMET00506 0.029 0.027 DBMET00486 | DBMET00506 | |
| 0.005 | 0.808 | 0.215 | Cystathionine beta-synthase inhibitor | 0.215 0.021 DBMET00503 0.173 0.032 DBMET00506 0.183 0.029 DBMET00508 0.196 0.025 DBMET00486 | DBMET00503 | |
| 0.036 | 0.84 | 0.35 | 5 Hydroxytryptamine release stimulant | 0.262 0.084 DBMET00503 0.35 0.057 DBMET00506 0.248 0.09 DBMET00508 0.248 0.09 DBMET00486 | DBMET00506 | |
| 0.005 | 0.81 | 0.375 | Insulin sensitizer | 0.235 0.044 DBMET00503 0.375 0.008 DBMET00506 0.242 0.039 DBMET00508 0.33 0.011 DBMET00486 | DBMET00506 | |
| 0.001 | 0.806 | 0.036 | AMPA 1 receptor antagonist | 0.036 0.017 DBMET00506 0.025 0.024 DBMET00508 | DBMET00506 | |
| 0.006 | 0.814 | 0.094 | Myeloperoxidase inhibitor | 0.094 0.042 DBMET00486 | DBMET00486 | |
| 0.003 | 0.811 | 0.043 | Sphingosine kinase 1 inhibitor | 0.043 0.025 DBMET00486 | DBMET00486 | |
| 0.001 | 0.81 | 0.116 | Kainate receptor 2 antagonist | 0.059 0.012 DBMET00503 0.116 0.004 DBMET00506 0.079 0.007 DBMET00508 0.083 0.006 DBMET00486 | DBMET00506 | |
| 0.011 | 0.821 | 0.135 | Melanin inhibitor | 0.135 0.105 DBMET00503 0.125 0.124 DBMET00506 0.127 0.119 DBMET00508 0.135 0.104 DBMET00486 | DBMET00486 | |
| 0.004 | 0.818 | 0.054 | Tryptophan 5 hydroxylase inhibitor | 0.054 0.004 DBMET00503 0.051 0.005 DBMET00506 0.046 0.007 DBMET00508 0.049 0.006 DBMET00486 | DBMET00503 | |
| 0.009 | 0.826 | 0.203 | Antibacterial (Helicobacter pylori) | 0.203 0.021 DBMET00503 0.114 0.091 DBMET00506 0.168 0.034 DBMET00486 | DBMET00503 | |
| 0.002 | 0.821 | 0.055 | Cholecystokinin A agonist | 0.055 0.005 DBMET00506 | DBMET00506 | |
| 0.006 | 0.825 | 0.275 | Non-steroidal antiinflammatory agent | 0.275 0.034 DBMET00506 0.263 0.038 DBMET00486 | DBMET00506 | |
| 0.05 | 0.869 | 0.166 | 5 Hydroxytryptamine 3E antagonist | 0.166 0.148 DBMET00506 | DBMET00506 | |
| 0.014 | 0.839 | 0.2 | Photosensitizer | 0.113 0.067 DBMET00503 0.2 0.013 DBMET00506 0.125 0.051 DBMET00508 0.154 0.029 DBMET00486 | DBMET00506 | |
| 0.005 | 0.83 | 0.113 | Protease 3C (Human rhinovirus) inhibitor | 0.113 0.011 DBMET00506 0.064 0.044 DBMET00508 0.102 0.015 DBMET00486 | DBMET00506 | |
| 0.002 | 0.828 | 0.045 | Histamine H2 receptor agonist | 0.045 0.026 DBMET00486 | DBMET00486 | |
| 0.005 | 0.833 | 0.188 | Arachidonic acid antagonist | 0.159 0.077 DBMET00503 0.188 0.045 DBMET00506 0.151 0.088 DBMET00508 0.161 0.076 DBMET00486 | DBMET00506 | |
| 0.002 | 0.831 | 0.241 | Glycine transporter 2 inhibitor | 0.241 0.004 DBMET00506 0.079 0.018 DBMET00508 0.123 0.01 DBMET00486 | DBMET00506 | |
| 0.002 | 0.832 | 0.107 | Integrin alpha4 antagonist | 0.099 0.006 DBMET00503 0.107 0.005 DBMET00506 0.06 0.01 DBMET00508 0.089 0.007 DBMET00486 | DBMET00506 | |
| 0.004 | 0.834 | 0.044 | Nicotinic receptor beta4 subunit antagonist | 0.044 0.019 DBMET00506 | DBMET00506 | |
| 0.01 | 0.841 | 0.081 | Vanilloid agonist | 0.081 0.068 DBMET00508 | DBMET00508 | |
| 0.011 | 0.842 | 0.143 | Vanilloid 1 agonist | 0.12 0.089 DBMET00503 0.143 0.045 DBMET00506 0.129 0.069 DBMET00508 0.134 0.059 DBMET00486 | DBMET00506 | |
| 0.014 | 0.845 | 0.145 | Glutamate (mGluR7) agonist | 0.111 0.041 DBMET00503 0.145 0.014 DBMET00506 0.123 0.028 DBMET00508 0.125 0.025 DBMET00486 | DBMET00506 | |
| 0.003 | 0.838 | 0.066 | Sphingosine kinase inhibitor | 0.066 0.029 DBMET00486 | DBMET00486 | |
| 0.001 | 0.839 | 0.096 | Methionyl aminopeptidase 2 inhibitor | 0.065 0.005 DBMET00506 0.096 0.004 DBMET00486 | DBMET00486 | |
| 0.008 | 0.846 | 0.049 | Bombesin 2 receptor antagonist | 0.047 0.039 DBMET00503 0.049 0.034 DBMET00506 0.045 0.043 DBMET00486 | DBMET00506 | |
| 0.005 | 0.844 | 0.152 | Botulinum neurotoxin type A inhibitor | 0.152 0.004 DBMET00503 0.144 0.005 DBMET00506 0.134 0.005 DBMET00508 0.077 0.019 DBMET00486 | DBMET00503 | |
| 0.001 | 0.842 | 0.072 | Carbonic anhydrase IV inhibitor | 0.072 0.013 DBMET00503 0.039 0.034 DBMET00506 0.054 0.022 DBMET00508 | DBMET00503 | |
| 0.002 | 0.844 | 0.075 | Integrin beta7 antagonist | 0.035 0.008 DBMET00503 0.075 0.005 DBMET00506 0.029 0.01 DBMET00508 0.041 0.007 DBMET00486 | DBMET00506 | |
| 0.007 | 0.849 | 0.066 | Human rhinovirus A protease inhibitor | 0.057 0.037 DBMET00503 0.066 0.031 DBMET00506 0.049 0.044 DBMET00508 | DBMET00506 | |
| 0.004 | 0.847 | 0.097 | Carbonic anhydrase stimulant | 0.089 0.022 DBMET00503 0.085 0.024 DBMET00506 0.084 0.024 DBMET00508 0.097 0.019 DBMET00486 | DBMET00486 | |
| 0.002 | 0.847 | 0.063 | Oxytocin agonist | 0.062 0.015 DBMET00503 0.056 0.019 DBMET00506 0.058 0.018 DBMET00508 0.063 0.014 DBMET00486 | DBMET00486 | |
| 0.002 | 0.847 | 0.111 | VLA-4 antagonist | 0.111 0.005 DBMET00503 0.101 0.005 DBMET00506 0.081 0.008 DBMET00508 0.096 0.006 DBMET00486 | DBMET00503 | |
| 0 | 0.847 | 0.055 | Kainate receptor 1 antagonist | 0.033 0.009 DBMET00503 0.046 0.006 DBMET00506 0.047 0.005 DBMET00508 0.055 0.005 DBMET00486 | DBMET00486 | |
| 0.003 | 0.849 | 0.071 | Lysophosphatidic acid 3 receptor antagonist | 0.058 0.024 DBMET00503 0.071 0.014 DBMET00506 0.057 0.026 DBMET00508 0.068 0.016 DBMET00486 | DBMET00506 | |
| 0.001 | 0.851 | 0.079 | Carbonic anhydrase I inhibitor | 0.062 0.034 DBMET00503 0.079 0.025 DBMET00508 | DBMET00508 | |
| 0.003 | 0.856 | 0.33 | Glutamate (mGluR1) agonist | 0.131 0.003 DBMET00503 0.245 0.002 DBMET00506 0.153 0.003 DBMET00508 0.33 0.002 DBMET00486 | DBMET00486 | |
| 0.003 | 0.857 | 0.237 | Integrin antagonist | 0.237 0.005 DBMET00503 0.152 0.01 DBMET00506 0.148 0.01 DBMET00508 0.141 0.011 DBMET00486 | DBMET00503 | |
| 0.001 | 0.857 | 0.054 | Carbonic anhydrase VB inhibitor | 0.054 0.041 DBMET00503 | DBMET00503 | |
| 0.004 | 0.859 | 0.068 | Macrophage elastase inhibitor | 0.068 0.015 DBMET00503 0.061 0.018 DBMET00506 0.064 0.017 DBMET00508 0.043 0.03 DBMET00486 | DBMET00503 | |
| 0.007 | 0.864 | 0.13 | Antipruritic | 0.13 0.123 DBMET00506 | DBMET00506 | |
| 0.001 | 0.859 | 0.064 | Carbonic anhydrase II inhibitor | 0.052 0.042 DBMET00503 0.064 0.032 DBMET00508 | DBMET00508 | |
| 0.001 | 0.86 | 0.128 | Kainate receptor antagonist | 0.059 0.017 DBMET00503 0.128 0.005 DBMET00506 0.077 0.01 DBMET00508 0.089 0.009 DBMET00486 | DBMET00506 | |
| 0.001 | 0.862 | 0.032 | ATP citrate lysase inhibitor | 0.032 0.022 DBMET00486 | DBMET00486 | |
| 0.004 | 0.865 | 0.28 | Ferrochelatase inhibitor | 0.28 0.009 DBMET00503 0.222 0.018 DBMET00506 0.253 0.013 DBMET00508 0.253 0.013 DBMET00486 | DBMET00503 | |
| 0 | 0.862 | 0.012 | Integrin beta2 antagonist | 0.012 0.009 DBMET00506 | DBMET00506 | |
| 0.004 | 0.867 | 0.305 | Integrin alpha5beta1 antagonist | 0.305 0.004 DBMET00503 0.043 0.025 DBMET00506 0.115 0.005 DBMET00508 0.05 0.018 DBMET00486 | DBMET00503 | |
| 0.004 | 0.867 | 0.202 | Glutamate (mGluR) agonist | 0.159 0.013 DBMET00506 0.087 0.028 DBMET00508 0.202 0.009 DBMET00486 | DBMET00486 | |
| 0.012 | 0.875 | 0.259 | Neuropeptide Y2 antagonist | 0.188 0.143 DBMET00503 0.259 0.048 DBMET00506 0.197 0.125 DBMET00508 0.204 0.112 DBMET00486 | DBMET00506 | |
| 0.002 | 0.866 | 0.052 | Integrin alpha4beta7 antagonist | 0.052 0.005 DBMET00503 0.05 0.005 DBMET00506 0.034 0.008 DBMET00508 0.033 0.008 DBMET00486 | DBMET00503 | |
| 0.005 | 0.87 | 0.068 | Cathepsin G inhibitor | 0.065 0.06 DBMET00503 0.068 0.056 DBMET00506 | DBMET00506 | |
| 0.002 | 0.869 | 0.031 | ICAM 1 antagonist | 0.031 0.006 DBMET00503 0.03 0.007 DBMET00506 0.024 0.013 DBMET00508 0.022 0.019 DBMET00486 | DBMET00503 | |
| 0.008 | 0.876 | 0.072 | Immunoglobulin Fc receptor antagonist | 0.072 0.009 DBMET00503 0.069 0.011 DBMET00508 0.062 0.02 DBMET00486 | DBMET00503 | |
| 0.002 | 0.871 | 0.342 | Monophenol monooxygenase inhibitor | 0.342 0.014 DBMET00503 0.106 0.071 DBMET00506 0.218 0.029 DBMET00508 0.142 0.05 DBMET00486 | DBMET00503 | |
| 0.003 | 0.872 | 0.159 | Sphingosine 1-phosphate receptor 2 antagonist | 0.123 0.09 DBMET00503 0.142 0.052 DBMET00506 0.134 0.066 DBMET00508 0.159 0.031 DBMET00486 | DBMET00486 | |
| 0.001 | 0.874 | 0.141 | NMDA receptor glycine site agonist | 0.095 0.019 DBMET00503 0.141 0.005 DBMET00506 0.093 0.02 DBMET00508 0.105 0.014 DBMET00486 | DBMET00506 | |
| 0.005 | 0.878 | 0.193 | M17 leucyl aminopeptidase inhibitor | 0.193 0.035 DBMET00503 0.18 0.04 DBMET00506 0.184 0.039 DBMET00508 0.167 0.046 DBMET00486 | DBMET00503 | |
| 0.01 | 0.886 | 0.447 | Insulysin inhibitor | 0.447 0.015 DBMET00503 0.332 0.041 DBMET00506 0.412 0.02 DBMET00508 0.347 0.035 DBMET00486 | DBMET00503 | |
| 0.009 | 0.886 | 0.191 | Chymotrypsin inhibitor | 0.191 0.01 DBMET00503 0.074 0.063 DBMET00506 0.088 0.045 DBMET00508 0.075 0.061 DBMET00486 | DBMET00503 | |
| 0.004 | 0.882 | 0.041 | p53 inhibitor | 0.041 0.02 DBMET00506 | DBMET00506 | |
| 0.005 | 0.885 | 0.194 | Prolactin inhibitor | 0.124 0.035 DBMET00503 0.194 0.01 DBMET00506 0.119 0.039 DBMET00508 0.128 0.033 DBMET00486 | DBMET00506 | |
| 0.004 | 0.883 | 0.098 | GABA B receptor agonist | 0.096 0.019 DBMET00503 0.09 0.026 DBMET00506 0.09 0.026 DBMET00508 0.098 0.018 DBMET00486 | DBMET00486 | |
| 0.001 | 0.883 | 0.071 | Carbonic anhydrase inhibitor | 0.056 0.05 DBMET00503 0.071 0.039 DBMET00508 | DBMET00508 | |
| 0.004 | 0.887 | 0.377 | Mannose-6-phosphate isomerase inhibitor | 0.377 0.003 DBMET00503 0.231 0.017 DBMET00508 0.138 0.076 DBMET00486 | DBMET00503 | |
| 0.004 | 0.89 | 0.123 | Phospholipase D inhibitor | 0.123 0.005 DBMET00503 0.114 0.008 DBMET00508 | DBMET00503 | |
| 0.003 | 0.891 | 0.28 | Alkaline phosphatase inhibitor | 0.28 0.015 DBMET00503 0.11 0.099 DBMET00506 0.178 0.043 DBMET00508 0.113 0.095 DBMET00486 | DBMET00503 | |
| 0.007 | 0.897 | 0.116 | Sphingosine 1-phosphate receptor 4 antagonist | 0.116 0.08 DBMET00506 | DBMET00506 | |
| 0.003 | 0.893 | 0.02 | Integrin alphaVbeta3 antagonist | 0.02 0.017 DBMET00503 0.02 0.017 DBMET00486 | DBMET00486 | |
| 0.005 | 0.897 | 0.101 | Keratolytic | 0.09 0.038 DBMET00503 0.101 0.03 DBMET00506 0.077 0.053 DBMET00508 0.088 0.04 DBMET00486 | DBMET00506 | |
| 0.008 | 0.902 | 0.25 | Neurotrophic factor enhancer | 0.25 0.038 DBMET00506 0.179 0.099 DBMET00486 | DBMET00506 | |
| 0.005 | 0.901 | 0.135 | Cyclooxygenase inhibitor | 0.135 0.083 DBMET00506 | DBMET00506 | |
| 0.001 | 0.899 | 0.013 | Integrin alphaVbeta6 antagonist | 0.013 0.012 DBMET00486 | DBMET00486 | |
| 0.003 | 0.905 | 0.319 | Anesthetic general | 0.143 0.122 DBMET00503 0.319 0.029 DBMET00506 0.153 0.111 DBMET00486 | DBMET00506 | |
| 0.004 | 0.908 | 0.168 | Sphingosine 1-phosphate receptor 5 antagonist | 0.147 0.066 DBMET00503 0.148 0.065 DBMET00506 0.139 0.081 DBMET00508 0.168 0.036 DBMET00486 | DBMET00486 | |
| 0.008 | 0.913 | 0.078 | D-Ala-D-Ala ligase inhibitor | 0.078 0.075 DBMET00506 | DBMET00506 | |
| 0.002 | 0.907 | 0.048 | Cholecystokinin B antagonist | 0.048 0.011 DBMET00506 | DBMET00506 | |
| 0.002 | 0.909 | 0.086 | Cholecystokinin A antagonist | 0.086 0.011 DBMET00506 | DBMET00506 | |
| 0.001 | 0.91 | 0.067 | Thromboxane A2 antagonist | 0.067 0.024 DBMET00506 0.048 0.038 DBMET00486 | DBMET00506 | |
| 0.006 | 0.916 | 0.104 | Carbonic anhydrase VI inhibitor | 0.104 0.037 DBMET00503 0.087 0.05 DBMET00508 | DBMET00503 | |
| 0.001 | 0.911 | 0.143 | Methionyl aminopeptidase 1 inhibitor | 0.096 0.004 DBMET00506 0.143 0.003 DBMET00486 | DBMET00486 | |
| 0.004 | 0.915 | 0.252 | Thiol protease inhibitor | 0.128 0.101 DBMET00503 0.252 0.026 DBMET00506 0.154 0.065 DBMET00508 0.24 0.029 DBMET00486 | DBMET00506 | |
| 0.002 | 0.913 | 0.064 | Cathepsin L inhibitor | 0.064 0.034 DBMET00503 0.054 0.045 DBMET00506 0.057 0.041 DBMET00486 | DBMET00503 | |
| 0.002 | 0.914 | 0.054 | Leukotriene C antagonist | 0.054 0.049 DBMET00486 | DBMET00486 | |
| 0.003 | 0.916 | 0.119 | Falcipain 3 inhibitor | 0.119 0.054 DBMET00486 | DBMET00486 | |
| 0.002 | 0.915 | 0.054 | Factor XIIIa inhibitor | 0.036 0.027 DBMET00503 0.054 0.014 DBMET00506 0.048 0.017 DBMET00508 0.033 0.031 DBMET00486 | DBMET00506 | |
| 0.004 | 0.918 | 0.115 | Cyclooxygenase 2 inhibitor | 0.115 0.086 DBMET00506 | DBMET00506 | |
| 0.003 | 0.92 | 0.16 | Beta amyloid protein antagonist | 0.16 0.034 DBMET00503 0.104 0.084 DBMET00508 | DBMET00503 | |
| 0.004 | 0.921 | 0.047 | VCAM-1 antagonist | 0.047 0.011 DBMET00503 0.043 0.017 DBMET00506 0.043 0.017 DBMET00508 0.047 0.012 DBMET00486 | DBMET00486 | |
| 0.004 | 0.921 | 0.256 | Neurotensin receptor agonist | 0.256 0.02 DBMET00503 0.209 0.03 DBMET00506 0.243 0.022 DBMET00508 0.201 0.034 DBMET00486 | DBMET00503 | |
| 0.004 | 0.922 | 0.047 | VCAM antagonist | 0.047 0.011 DBMET00503 0.043 0.017 DBMET00506 0.043 0.017 DBMET00508 0.047 0.012 DBMET00486 | DBMET00486 | |
| 0.001 | 0.92 | 0.032 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.031 0.03 DBMET00506 0.032 0.029 DBMET00486 | DBMET00486 | |
| 0.002 | 0.922 | 0.058 | Dopamine beta hydroxylase inhibitor | 0.058 0.018 DBMET00503 0.052 0.026 DBMET00508 | DBMET00503 | |
| 0.001 | 0.922 | 0.059 | Leukotriene antagonist | 0.059 0.052 DBMET00486 | DBMET00486 | |
| 0.001 | 0.923 | 0.063 | Peptide deformylase inhibitor | 0.057 0.008 DBMET00503 0.053 0.009 DBMET00506 0.063 0.006 DBMET00508 0.048 0.01 DBMET00486 | DBMET00508 | |
| 0.001 | 0.927 | 0.063 | Thromboxane antagonist | 0.063 0.03 DBMET00506 0.047 0.046 DBMET00486 | DBMET00506 | |
| 0.002 | 0.928 | 0.079 | HCV NS3/NS4A protease inhibitor | 0.079 0.011 DBMET00503 0.058 0.023 DBMET00506 0.066 0.017 DBMET00508 0.049 0.034 DBMET00486 | DBMET00503 | |
| 0.001 | 0.928 | 0.038 | AMPA 3 receptor antagonist | 0.028 0.022 DBMET00503 0.028 0.022 DBMET00506 0.038 0.014 DBMET00508 0.035 0.017 DBMET00486 | DBMET00508 | |
| 0.007 | 0.937 | 0.149 | HIV-1 integrase (Overall Integration) inhibitor | 0.149 0.026 DBMET00503 0.137 0.03 DBMET00508 0.08 0.078 DBMET00486 | DBMET00503 | |
| 0.001 | 0.933 | 0.055 | NMDA receptor subunit 3B antagonist | 0.044 0.03 DBMET00503 0.048 0.027 DBMET00506 0.055 0.022 DBMET00508 0.049 0.025 DBMET00486 | DBMET00508 | |
| 0.001 | 0.933 | 0.08 | NMDA receptor subunit 3A antagonist | 0.064 0.016 DBMET00503 0.041 0.024 DBMET00506 0.049 0.02 DBMET00508 0.08 0.012 DBMET00486 | DBMET00486 | |
| 0.001 | 0.933 | 0.043 | Glycine transporter inhibitor | 0.043 0.038 DBMET00506 | DBMET00506 | |
| 0.003 | 0.937 | 0.088 | Histone deacetylase 5 inhibitor | 0.088 0.01 DBMET00508 | DBMET00508 | |
| 0.001 | 0.936 | 0.018 | Caspase 8 inhibitor | 0.018 0.017 DBMET00486 | DBMET00486 | |
| 0.003 | 0.937 | 0.122 | Neuropeptide Y1 antagonist | 0.122 0.117 DBMET00506 | DBMET00506 | |
| 0.002 | 0.936 | 0.104 | NMDA receptor antagonist | 0.074 0.073 DBMET00503 0.104 0.044 DBMET00506 0.083 0.061 DBMET00486 | DBMET00506 | |
| 0.001 | 0.936 | 0.092 | Metalloproteinase-3 inhibitor | 0.092 0.012 DBMET00503 0.083 0.015 DBMET00506 0.087 0.013 DBMET00508 0.062 0.023 DBMET00486 | DBMET00503 | |
| 0.004 | 0.939 | 0.095 | MDM2 inhibitor | 0.064 0.059 DBMET00503 0.095 0.009 DBMET00506 0.065 0.055 DBMET00508 0.069 0.04 DBMET00486 | DBMET00506 | |
| 0.001 | 0.938 | 0.125 | NMDA 2C receptor antagonist | 0.08 0.025 DBMET00503 0.125 0.01 DBMET00506 0.098 0.016 DBMET00508 0.094 0.018 DBMET00486 | DBMET00506 | |
| 0.001 | 0.939 | 0.056 | Calcium-sensing receptor agonist | 0.025 0.021 DBMET00503 0.033 0.011 DBMET00506 0.056 0.005 DBMET00486 | DBMET00486 | |
| 0.001 | 0.939 | 0.08 | NMDA 2 receptor antagonist | 0.08 0.043 DBMET00506 | DBMET00506 | |
| 0.001 | 0.941 | 0.054 | LFA antagonist | 0.04 0.008 DBMET00503 0.054 0.005 DBMET00506 0.031 0.015 DBMET00508 0.025 0.024 DBMET00486 | DBMET00506 | |
| 0.004 | 0.945 | 0.146 | Dual specificity phosphatase 3 inhibitor | 0.146 0.1 DBMET00503 | DBMET00503 | |
| 0.002 | 0.946 | 0.075 | Cholecystokinin antagonist | 0.075 0.013 DBMET00506 | DBMET00506 | |
| 0.001 | 0.944 | 0.152 | Neutrophil collagenase inhibitor | 0.143 0.013 DBMET00503 0.087 0.028 DBMET00506 0.152 0.012 DBMET00508 0.07 0.04 DBMET00486 | DBMET00508 | |
| 0.001 | 0.945 | 0.131 | Matrix metalloproteinase (membrane-type) inhibitor | 0.091 0.016 DBMET00503 0.078 0.021 DBMET00506 0.131 0.01 DBMET00508 0.061 0.032 DBMET00486 | DBMET00508 | |
| 0.001 | 0.945 | 0.061 | Glutamate (mGluR group I) agonist | 0.043 0.039 DBMET00506 0.061 0.022 DBMET00486 | DBMET00486 | |
| 0.002 | 0.947 | 0.288 | Phospholipase A2 inhibitor | 0.208 0.038 DBMET00503 0.251 0.023 DBMET00506 0.216 0.035 DBMET00508 0.288 0.015 DBMET00486 | DBMET00486 | |
| 0.001 | 0.947 | 0.104 | NMDA 2A receptor antagonist | 0.044 0.043 DBMET00503 0.104 0.012 DBMET00506 0.057 0.031 DBMET00508 0.059 0.03 DBMET00486 | DBMET00506 | |
| 0.005 | 0.952 | 0.124 | NADPH oxidase inhibitor | 0.124 0.077 DBMET00506 | DBMET00506 | |
| 0.006 | 0.953 | 0.037 | Aggrecanase 1 inhibitor | 0.037 0.033 DBMET00503 | DBMET00503 | |
| 0.003 | 0.953 | 0.299 | Transcription factor STAT3 inhibitor | 0.299 0.054 DBMET00506 0.199 0.134 DBMET00508 | DBMET00506 | |
| 0.002 | 0.957 | 0.108 | Secretase beta inhibitor | 0.108 0.014 DBMET00506 | DBMET00506 | |
| 0.001 | 0.956 | 0.135 | Metalloproteinase-2 inhibitor | 0.1 0.038 DBMET00503 0.135 0.023 DBMET00506 0.127 0.026 DBMET00508 0.083 0.049 DBMET00486 | DBMET00506 | |
| 0.001 | 0.957 | 0.165 | Sphingosine 1-phosphate receptor 4 agonist | 0.077 0.039 DBMET00503 0.165 0.006 DBMET00506 0.088 0.032 DBMET00508 0.133 0.013 DBMET00486 | DBMET00506 | |
| 0.001 | 0.957 | 0.042 | Dihydroorotase inhibitor | 0.042 0.034 DBMET00503 | DBMET00503 | |
| 0.007 | 0.964 | 0.244 | Gastrin inhibitor | 0.236 0.097 DBMET00503 0.244 0.087 DBMET00506 0.215 0.126 DBMET00508 0.239 0.092 DBMET00486 | DBMET00506 | |
| 0.002 | 0.96 | 0.071 | Histone deacetylase class IIa inhibitor | 0.071 0.01 DBMET00508 | DBMET00508 | |
| 0.002 | 0.96 | 0.169 | Urease inhibitor | 0.169 0.015 DBMET00503 0.102 0.065 DBMET00506 0.151 0.022 DBMET00508 0.105 0.061 DBMET00486 | DBMET00503 | |
| 0.001 | 0.959 | 0.107 | Matrix metalloproteinase 1 inhibitor | 0.095 0.015 DBMET00503 0.059 0.032 DBMET00506 0.107 0.011 DBMET00508 0.061 0.031 DBMET00486 | DBMET00508 | |
| 0.001 | 0.96 | 0.167 | Metalloproteinase-9 inhibitor | 0.154 0.014 DBMET00503 0.116 0.026 DBMET00506 0.167 0.012 DBMET00508 0.082 0.042 DBMET00486 | DBMET00508 | |
| 0.001 | 0.961 | 0.187 | Glutamate receptor agonist | 0.133 0.022 DBMET00503 0.187 0.012 DBMET00506 0.106 0.033 DBMET00508 0.18 0.013 DBMET00486 | DBMET00506 | |
| 0.001 | 0.962 | 0.168 | Matrix metalloproteinase inhibitor | 0.146 0.014 DBMET00503 0.098 0.027 DBMET00506 0.168 0.011 DBMET00508 0.097 0.028 DBMET00486 | DBMET00508 | |
| 0.003 | 0.964 | 0.156 | Caspase 3 inhibitor | 0.116 0.066 DBMET00503 0.156 0.024 DBMET00506 0.12 0.059 DBMET00508 0.139 0.037 DBMET00486 | DBMET00506 | |
| 0.001 | 0.966 | 0.043 | Leukocyte elastase inhibitor | 0.043 0.029 DBMET00503 0.043 0.029 DBMET00506 | DBMET00506 | |
| 0.002 | 0.967 | 0.087 | Histone deacetylase 3 inhibitor | 0.087 0.008 DBMET00508 | DBMET00508 | |
| 0.001 | 0.966 | 0.078 | Histone deacetylase inhibitor | 0.078 0.033 DBMET00508 | DBMET00508 | |
| 0.002 | 0.967 | 0.09 | Gastric antisecretory | 0.09 0.078 DBMET00506 | DBMET00506 | |
| 0.002 | 0.968 | 0.06 | Histone deacetylase 1 inhibitor | 0.06 0.011 DBMET00508 | DBMET00508 | |
| 0.001 | 0.967 | 0.276 | Calpain inhibitor | 0.276 0.044 DBMET00503 0.238 0.076 DBMET00506 0.261 0.055 DBMET00508 0.18 0.135 DBMET00486 | DBMET00503 | |
| 0.001 | 0.968 | 0.098 | Collagenase 3 inhibitor | 0.065 0.036 DBMET00503 0.062 0.039 DBMET00506 0.098 0.016 DBMET00508 0.053 0.051 DBMET00486 | DBMET00508 | |
| 0.004 | 0.971 | 0.118 | Protein-tyrosine phosphatase inhibitor | 0.118 0.116 DBMET00486 | DBMET00486 | |
| 0.002 | 0.97 | 0.076 | Histone deacetylase 10 inhibitor | 0.033 0.019 DBMET00503 0.076 0.007 DBMET00508 | DBMET00508 | |
| 0.001 | 0.969 | 0.265 | Calpain 2 inhibitor | 0.212 0.177 DBMET00503 0.265 0.139 DBMET00506 0.237 0.158 DBMET00508 | DBMET00506 | |
| 0.001 | 0.969 | 0.06 | Prolyl endopeptidase inhibitor | 0.06 0.024 DBMET00506 0.057 0.027 DBMET00486 | DBMET00506 | |
| 0 | 0.969 | 0.04 | Glucagon receptor antagonist | 0.04 0.014 DBMET00506 | DBMET00506 | |
| 0.002 | 0.971 | 0.087 | Interleukin 1 beta converting enzyme inhibitor | 0.087 0.077 DBMET00486 | DBMET00486 | |
| 0.001 | 0.97 | 0.036 | Histone deacetylase 9 inhibitor | 0.036 0.033 DBMET00508 | DBMET00508 | |
| 0.001 | 0.971 | 0.056 | Histone deacetylase 8 inhibitor | 0.056 0.018 DBMET00508 | DBMET00508 | |
| 0.004 | 0.974 | 0.06 | Transcription factor AP-1 inhibitor | 0.06 0.044 DBMET00506 | DBMET00506 | |
| 0.001 | 0.971 | 0.04 | Histone deacetylase 7 inhibitor | 0.04 0.023 DBMET00508 | DBMET00508 | |
| 0.003 | 0.973 | 0.207 | Antiamyloidogenic | 0.159 0.135 DBMET00503 0.207 0.095 DBMET00506 0.192 0.105 DBMET00486 | DBMET00506 | |
| 0.002 | 0.972 | 0.043 | Prostaglandin EP3 antagonist | 0.043 0.013 DBMET00486 | DBMET00486 | |
| 0.002 | 0.974 | 0.126 | Histone deacetylase 11 inhibitor | 0.045 0.015 DBMET00503 0.126 0.005 DBMET00508 | DBMET00508 | |
| 0.002 | 0.974 | 0.126 | Histone deacetylase class IV inhibitor | 0.045 0.015 DBMET00503 0.126 0.005 DBMET00508 | DBMET00508 | |
| 0.004 | 0.976 | 0.146 | Dual specificity phosphatase inhibitor | 0.146 0.098 DBMET00503 | DBMET00503 | |
| 0.002 | 0.977 | 0.078 | Histone deacetylase 2 inhibitor | 0.078 0.011 DBMET00508 | DBMET00508 | |
| 0.002 | 0.977 | 0.064 | Histone deacetylase class II inhibitor | 0.064 0.01 DBMET00508 | DBMET00508 | |
| 0.001 | 0.979 | 0.053 | Nicotinic receptor alpha3 subunit antagonist | 0.053 0.023 DBMET00503 0.04 0.035 DBMET00508 | DBMET00503 | |
| 0.002 | 0.98 | 0.06 | Histone deacetylase 4 inhibitor | 0.06 0.01 DBMET00508 | DBMET00508 | |
| 0.002 | 0.98 | 0.136 | Proteasome inhibitor | 0.136 0.055 DBMET00506 0.105 0.081 DBMET00486 | DBMET00506 | |
| 0.002 | 0.982 | 0.069 | Histone deacetylase 6 inhibitor | 0.024 0.019 DBMET00503 0.069 0.009 DBMET00508 | DBMET00508 | |
| 0.002 | 0.982 | 0.071 | Histone deacetylase class IIb inhibitor | 0.025 0.019 DBMET00503 0.071 0.009 DBMET00508 | DBMET00508 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |